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Abstract 
Surfactant activity is generally associated with small molecules rather than biological 
macromolecules like proteins. Only a few proteins have good intrinsic surfactant activity, 
an example being the natural surfactant ranaspumin 2 (Rsn2) from the foam nests of the 
túngara frog. In solution, Rsn2 has a hydrophobic core and hydrophilic exterior, but 
when Rsn2 comes in contact with an air-water interface, it changes conformation to 
expose its hydrophobic core to interact with the air and present a hydrophilic face to the 
water. The unique combination of biocompatibility along with surface activity offers the 
possibility of developing biomedical applications based on Rsn2. Some of the possible 
applications, including cell patterning, functionalising scaffolds and stabilising droplets , 
have been explored in the work described in this thesis.  
The ability of Rsn2 to coat hydrophobic surfaces persistently, rendering them wettable 
and the nature of coating and interaction with the surfaces were investigated. This 
formed the basis for the development of a method to coat a range of hydrophobic 
polymers, which are commonly used for biomedical applications. These Rsn2 coated 
surfaces were tested for their capability to control cell adhesion on surfaces which 
usually do not support cell adhesion. Rsn2 coating was demonstrated to promote, and 
thus allowed the spatial control over, cell adhesion on otherwise non-cell compatible 
surfaces.  
The potential of Rsn2 to be used as a protein fusion partner for the production of further 
functionalised cell engineering substrates was explored by constructing five different 
integerin binding sequence (IBS)-Rsn2 conjugates. Specific IBS-Rsn2 proteins proved 
successful in increasing the adhesion and biomineralising potential of osteoblasts isolated 
from neonatal rats.  
In addition, Rsn2's ability to stabilise microscopic oil droplets, and to solubilise fullerene 
were investigated. Rsn2 stabilised oil droplets were stable for more than six months.  
Thus, the surfactant properties of Rsn2 can be used for many potential biomedical 
applications.  
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Introduction 
Almost all proteins display some surface activity when agitated sufficiently vigorously, 
but this property is certainly not one that they have evolved to possess. However, there 
are a small number of proteins whose intrinsic surface activity appears to fulfil one of 
their primary functions. One such protein is ranaspumin-2 (Rsn2) found in foam nest of 
túngara frog.  The physical properties of Rsn2 offer an attractive opportunity for many 
biotechnological applications, including, coatings for nano-devices or medical implants 
and as an emulsifier in food and personal-care products. Work described in this thesis is 
mainly focused on using Rsn2’s ability to coat surfaces for developing a variety of 
biotechnological applications.   
1.1 Surfactant 
Surface tension is one of the important properties of a liquid and it arises from the 
interactions between the molecules that constitute a liquid. These molecules have 
cohesive forces between them, which attract them to each other and allow the surface of 
a liquid to resist an external force.  
Surface tension is the measure of the free energy of the surface per unit area (Myers, 
2005b). Surface tension is one of the important properties of liquids and it arises from the 
interactions between the molecules that constitute them. These molecules have cohesive 
forces between them, which attract them to one another and allow the surface of a liquid 
to resist an external force. Surface tension of a pure liquid, which is a constant value, can 
be measured by static surface measurements. For example water, which forms relatively 
strong intermolecular hydrogen bonds, generates a high surface tension (74.2 mN m-1) 
compared to other liquids, for example ethanol (22.3 mN m-1) and acetone (23.7 mN m-
1) where dipole-dipole interactions and van der Waal forces also exists (Myers, 2005b). 
Surface tension measurements are commonly made by the capillary rise method, Du 
Noüy ring tensiometer, pendant drop or sessile drop method, and micro trough 
tensiometry method. 
In the capillary rise method, a thin circular glass capillary is dipped into the liquid to be 
tested. If the liquid interaction with the capillary wall is favoured, then the liquid level 
will rises in the capillary and will generate a concave meniscus. In the opposite situation, 
a decrease in the liquid level will be observed in the capillary along with a 
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semispherically convex meniscus (Liu et al., 2016, Zhmud et al., 2000). The below 
formula is used for measuring surface tension in capillary rise method 
γ = rh dg/2 
Where γ is the liquid surface tension, r is the capillary radius, h is the height, d is the 
liquid density and g is the acceleration of gravity. 
The Du Noüy ring tensiometer uses a platinum ring, which is generally lowered into the 
liquid to be tested and lifted upwards, raising a meniscus of liquid along with it. The 
force required to raise the ring increases until the meniscus breaks, releasing the ring. 
The maximum force encountered by the ring is measured by a balance and used to 
calculate surface tension (Fox and Chrisman, 1952).  The below formula is used for 
measuring surface tension in method the Du Noüy ring tensiometer  
Wtot = Wr + 4π R γ = Wr + 2lγ 
Where Wtot  is the total force needed to detach the ring, Wr is the ring weight, R is the 
ring radius, γ is the liquid surface tension, and l is the width.  
The micro trough tensiometry method, also known as the Wilhelmy plate method, 
measures the surface tension of a test solution. For this a platinum rod attached to a 
computer-monitored microbalance is submerged into the test solution. The downward 
force exerted upon the rod by the surface is then calculated. The principle of the 
technique is similar to that of the du Noüy ring, however this gives the advantage of 
being able to measure surface tension in time-dependant manner (Vance, 2012, Wu et al., 
1999). The below formula is used for measuring surface tension in method the micro 
trough tensiometry   
Wtot = Wplate + 2 l γ cosθ 
Where Wtot  is the total force needed to detach the ring, Wr is the ring weight, R is the 
ring radius, γ is the liquid surface tension, and l is the width of the plate. 
The pendant drop or sessile drop method involves taking measurements of an 
axisymmetric fluid droplet, and using the Young–Laplace equation to calculate interfacial 
tension (Berry et al., 2015) The method is described in detail in section 2.3.2 and 2.3.4 of 
the thesis.  
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Surfactants are surface active molecules which modify the surface tension of the liquid 
by modifying the inter-molecular forces between molecules at the surface. Surfactants 
have the ability to reduce the surface tension at an interface, even though present in small 
concentrations as measured in the bulk solution. Synthetic surfactants are usually organic 
molecules with amphiphilic properties, and they are made up of hydrophilic (polar head) 
and hydrophobic (non-polar tail) groups. Consequently, they are soluble in both aqueous 
and non-aqueous solutions. The conventional surfactants are grouped as non-ionic, 
cationic, anionic or zwitterionic, depending upon the nature of their head group (Myers, 
2005a). 
 
 
Figure 1-1 The typical molecular structure of a surfactant (A) and an example of a synthetic surfactant 
Na-dodecyl sulphate (B).  
Upon mixing water and an immiscible hydrophobic liquid such as oil with surfactant, the 
surfactant occupies the water-oil interface and forms emulsions or micro-emulsions to 
avoid the direct oil/water contact. The surfactant molecules act cooperatively at an 
interface, and change the interfacial energy to function as wetting; emulsifying; foaming 
or suspending agents.  
 
Figure 1-2 Diagrammatic representation of water in oil emulsion stabilised by surfactant 
A wide variety of applications have increased the demand and production of surfactant 
molecules at global level. The global surfactant market was of US $30.65 billion in 2015 
and their demand is expected to increase by 4.4% in coming years (Market, 2016). Most 
of the synthetic surfactants are chemically derived from petroleum; nevertheless the 
interest in biological surfactants has been increasing steadily for environmental and 
industrial applications (Joshi et al., 2015).  
Hydrophobic 
 tail 
Hydrophilic 
head 
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1.2 Biosurfactants  
Biosurfactants, a type of surfactant, are amphiphilic molecules secreted extracellularly by 
cells to facilitate many physiological functions including antimicrobial activity, 
protecting them against wetting and allowing them to grow on water-immiscible 
substrates (Desai and Banat, 1997). Like surfactants, biosurfactants also contain 
hydrophobic and hydrophilic groups, and have the ability to reduce surface tension at the 
interface. They have generally been found to be low molecular weight molecules. 
According to their chemical composition, biosurfactants are classified as glycolipids, 
lipopeptides and fatty acids  (Reis et al., 2013).  The current mass produced sources and 
possible applications of a range of biosurfactants are shown in below (Table 1-1). 
Biosurfactants potentially offer notable advantages of reduced toxicity, biodegradability, 
eco-friendliness, bioremediation and digestibility (Banat et al., 2010) over the traditional 
chemical surfactants, and have found their applications in coatings and lubricants, 
pharma, crude oil recovery, health care, cosmetics and food processing industries (Desai 
and Banat, 1997).  
Biosurfactant Class Micro organism Application 
Glycolipids  Rhamnolipids 
(Edwards and Hayashi, 
1965) 
P. aeruginosa and P. putida 
  
Bioremediation,  
Biocontrol agent, 
Antifungal agent, 
Bioremediation 
 
Sophorolipids (Gautam 
and Tyagi, 2006) 
 
Candida bombicola and C. 
apicola 
Emulsifier, MEOR, alkane 
dissimilation 
Trehalose lipids 
(Asselineau and 
Asselineau, 1978) 
 
Rhodococcus spp. and 
Arthrobacter sp. 
Bioremediation, 
Antimicrobial agent 
Mannosylerythritol 
lipids 
(Reis et al., 2013) 
 
Candida antartica 
Neuroreceptor antagonist 
and Kurtzmanomyces sp 
Antimicrobial agent, 
Biomedical application 
Fatty acids Fatty acids, 
phospholipids and 
neutral lipids 
(Gautam and Tyagi, 
2006) 
 
Acinetobacter spp Biomedical applications 
Lipo Peptides Surfactin 
(Arima et al., 1968) 
 
Bacillus subtilis Antimicrobial agent, 
biomedical application 
 
Lichenysin 
(McInerney et al., 
1990) 
B. licheniformis Hemolytic and chelating 
agent 
 
Table 1-1 Major types of biosurfactants 
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The surfactant property is generally associated with the low molecular weight molecules, 
but some macromolecules, like proteins, are also surface active. Nearly all proteins are 
composed of amphiphilic polypeptides, but generally have the hydrophilic parts exposed 
on their surface and the hydrophobic parts buried. Most proteins are sensitive to surface 
effects and foaming will result in denaturation. This denatured proteins exhibits 
surfactant properties attributed to the exposure of hydrophobic groups, which were 
buried in their native structure (Cooper and Kennedy, 2010). Thus while most proteins 
are surfactant to a certain extent, they are not usually surface active in their native state. 
However, proteins that have intrinsic surfactant activity are termed as surfactant proteins. 
The surfactant proteins generally adsorb at air water interfaces. The process of adsorption 
at an air water interface gives rise to an emulsion.  
The surfactant proteins can be grouped into two classes: those that are active in presence 
of associated lipids (e.g., the pulmonary surfactants), and non-lipid-associated globular 
proteins. Both types of proteins and their mechanism of action are further discussed in 
the next sections, with the focus on the non-lipid associated surfactant proteins. 
1.3 Pulmonary Surfactant proteins  
The pulmonary surfactant proteins (SP) are the most well studied group of proteins 
linked with surfactant activity. Pulmonary surfactants are produced by the alveolar 
epithelial cell lining of the lungs to prevent alveolar collapse upon exhalation. Pulmonary 
surfactant is heterogeneous being composed of 90% lipids and 10% proteins by weight, 
the latter representing four surfactant associated proteins, designated as surfactant protein 
(SP)-A, SP-B, SP-C and SP-D. These proteins can be divided into two types, SP-B and 
SP-C are small hydrophobic proteins, while SP-A and SP-D are large hydrophilic 
proteins (Goerke, 1998). 
SP-A and SP-D have collagen-containing calcium-dependent lectins, and are therefore 
referred to as “collectins”. Both proteins are hydrophilic and have calcium dependent 
carbohydrate binding domains involved in innate host-defence functions (Kishore et al., 
2006, Sano and Kuroki, 2005). 
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Figure 1-3 The Schematic structure and relative size of the pulmonary surfactant proteins. SP-A, SP-B, 
SP-C, and SP-D stands for the four different types of surfactant proteins acting near a phospholipid 
bilayer (PL). Image taken from (Griese, 1999) 
The most abundant SP by weight is SP-A. SP-A is an octadecamer made up of ~ 32 kDa 
monomers, interacting with each other via disulphide linkages and noncovalent 
interactions (Griese, 1999). Each SP-A monomer has three structural motifs, a linking 
region that connects a long collagenous region to a globular region (Kishore et al., 2006). 
SP-A and SP-B along with endogenous surfactant are involved in the formation of 
tubular myelin (Goerke, 1998). 
The membrane associated SP-B is a 79 amino acid peptide weighing almost a 17.4- kDa 
(Zaltash et al., 2000, Johansson and Curstedt, 1997). Sp-B has a direct impact on the 
respiratory physiology and absence of it can result in lethal respiratory failure in 
deficient individuals (Melton et al., 2003). SP-B is mainly found in a dimeric state, 
where monomers are linked through three intrachain and one interchain disulphide 
linkages (Zaltash et al., 2000). 
The highly hydrophobic SP-C is expressed by alveolar type II cells (Griese, 1999). SP-C 
is a 35 amino acid, valine rich lipopeptide (Gustafsson et al., 1997). The structure of SP-
C mainly consists of a rigid 3.7 nm long alpha helix and a 2.3 nm central aliphatic 
domain, which is attached to the alpha helix (Johansson and Curstedt, 1997). Two 
palmitoyl chains are also linked to the N-terminus of SP-C via thio-ester bonds, allowing 
it to incorporate into the phospholipid monolayer (Gustafsson et al., 1997). The main 
function of SP-C is to facilitate the spreading of surfactant at the air/water interface 
(Pinto et al., 1995). SP-B is required for the full processing of SP-C and absence of SP-C 
is associated with severe respiratory diseases (Glasser et al., 2003).  
Hydrophilic SP-D surfactant protein weighs almost 43 kDa as a monomer (Zhang et al., 
2001). Electron microscopy shows that the native SP-D consists of 12 monomers 
forming four homologous trimers stabilised by interchain disulfide bonds (Zhang et al., 
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2001). The four trimers are directly linked  to the long collagen-like regions forming a 
cross shaped molecule with a width of approximately 92 nm (Griese, 1999). SP-D has an 
immunological role, but has no surfactant function. It has specific binding sites for 
macrophages and bacterial lipopolysaccharide and modulates the chemotaxis and 
oxidative bursts of macrophages and opsonizes various micro-organisms for easier 
phagocytosis (Griese, 1999).  
To summarise, pulmonary surfactant proteins play an important role in vital respiratory 
process in humans. However, these proteins rely mostly on their exposed amphiphilicity 
for their function and play a crucial role in organising lipids at the interface. It is the lipid 
rich surfactant mixture, which goes on to decrease the surface tension at the interface 
rather than the proteins themselves. Thus these proteins can be considered as mediators 
rather than the principal surfactants. 
1.4 Hydrophobins  
Another type of amphiphilic surfactant protein that has been studied in detail is the 
hydrophobin family. Hydrophobins are a group of surface active proteins that are 
secreted by filamentous fungi.  Hydrophobins are known to fulfil many important 
functions in fungal physiology, forming surface coatings for protection against 
desiccation and wetting, and reducing the surface tension of water to allow growth of 
aerial structures including hyphae and spores (Linder et al., 2005).  
Hydrophobins are small proteins of about 100 amino acids and 10 kDa in size. They have 
four disulphide bridges formed by eight conserved cysteine residues (Hou et al., 2009). 
Hydrophobins are divided into two classes (class I and II) based on differences in 
hydropathy pattern and biophysical properties. Both types self-assemble into an 
amphipathic film at a hydrophilic–hydrophobic interface. The protein aggregates of class 
I hydrophobins are more stable. They resist boiling in detergent and can only be 
dissolved in strong acids such as trifluoroacetic acid (TFA) and formic acid. In contrast, 
class II aggregates are less stable and can be dissolved using aqueous dilutions of organic 
solvents (Bonazza et al., 2015, Hou et al., 2009). 
Upon self-assembling at an interface, hydrophobins can very effectively invert the 
polarity of the surface. The N-terminal part determines wettability of the hydrophilic side 
of the assemblage (Hou et al., 2009). Class I hydrophobins self-assemble at interfaces 
into a monolayer of highly ordered mosaic ultrastructure of 10 nm wide rodlets (Wosten 
and de Vocht, 2000), which share some structural similarity to amyloid-like fibrils. By 
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contrast, class II hydrophobins lack fibrillar structure, but form films with a hexagonal 
structure and distinct repeating units (Paananen et al., 2003). Both the class of 
hydrophobins exist in an initial soluble state (monomeric for class I, and dimeric or 
tetrameric for class II) and transform to the final beta-sheet state, in which they are 
insoluble in water (Wosten and de Vocht, 2000, Meister et al., 2016). Their actions result 
in the formation of different types of highly ordered coatings, as mentioned earlier. 
 
 
Figure 1-4 Cartoon representation of the crystal structure of a hydrophobin class II monomer showing 
four symmetrically arranged disulphide bridges in yellow and orange, with the α-helix shown in red and 
the strands of the β-barrel in yellow. Diagram was created from PDB file2b97 using PyMOL software 
(Hakanpaa et al., 2006). 
The first crystal structure of a class II hydrophobin from Trichoderma reesei was solved 
at 1.0 Å resolution revealing that this globular protein is made up of a central β-barrel 
structure, consisting of two β-hairpins, and one short α-helix  (Hakanpää et al., 2004). 
Hydrophobin exhibits a novel fold, which is as shown in Figure 1-4. 
Hydrophobin exposes about half of its hydrophobic aliphatic residues to the surface, 
unlike most soluble proteins, and has a hydrophobic residues in the core that stabilises 
the structure (Linder et al., 2005). The disulphide bridges formed by cysteine residues 
provide further stabilization, and ensure that the protein will remain globular. To contrast, 
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other protein surfactant like Rsn2, Latherin/SPLUNC1 (discussed later in detail) also 
contain a disulphide each, but are not as topologically constrained by them. 
The unique properties of the hydrophobins have been appreciated and applied in 
numerous roles including: biomedical applications, fusion partners for protein 
purification and anti-fouling agents (Wösten and Scholtmeijer, 2015). 
1.5 Biofilm Surface Layer Protein A  
Bacillus subtilis is a gram-positive bacterium dwelling in soil. The bacteria often 
aggregate to form a community of individuals referred to as a biofilm (Ostrowski et al., 
2011). This biofilm provides resistance to liquid wetting. Studies have shown that the 
surface topology of biofilms plays a vital role in water repellence (Epstein et al., 2011, 
Ostrowski et al., 2011). Further investigation has shown that in B. subtilis, a biofilm 
surface layer protein A (BslA1) is the main contributor for repellence to surface wetting 
(Kobayashi and Iwano, 2012). BslA1 is a surfactant protein that forms a hydrophobic 
coating outside of the biofilm matrix, and is therefore referred to as bacterial raincoat 
(Hofer, 2013). 
Structure of BslA1 was recently solved using X-ray crystallography and its fold revealed 
that BslA1 belongs to a member of the immunoglobulin superfamily. The structure of 
BslA1 consists of one 310-helix and two β-sheets, one four stranded and one three 
stranded, stacked together. Linked to this main scaffold is a highly hydrophobic “cap” β-
sheet region,  comprising three short β-strands (Hofer, 2013). The crystal structure 
revealed two forms of the protein, one in which hydrophobic amino acids of the cap 
region are buried within the structure, which allows the protein to be monomeric in 
aqueous solution. The alternative conformation is believed to reveal what happens when 
BslA1 is at an air-water interface. The protein undergoes a limited conformational 
change, exposing the hydrophobic amino acids of the cap region to the hydrophobic 
surface and can then self-assemble into an ordered 2D rectangular lattice that stabilizes 
the interface (Bromley et al., 2015, Brandani et al., 2015). 
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Figure 1-5 Cartoon diagram showing structure of BslA1 determined by X-ray crystallography coloured 
red for α-helix and yellow for β-strand. The cap region, made up of three β-strands, is highlighted using 
blue colour. Image created from PDB file 4bhu using PyMOL software (Hobley et al., 2013b) 
The importance of the “cap” region residues was confirmed by replacing individual 
leucines with lysine residues in the centre of the cap. The resulting disruption in the 
formation of the 2D lattice suggests that leucine residues are involved in inter-monomer 
interactions. Thus proving the importance of the hydrophobic residues in cap region 
needed for interfacial stabilization of biofilms (Hobley, 2013). 
1.6 Latherin and SPLUNC1 
Latherin is a surfactant protein, identified from the sweat and saliva of horses and other 
equine species. It is believed to play a vital role in the process of evaporative cooling by 
wetting the waterproofed pelt (McDonald et al., 2009). Like humans, horses regulate 
their body temperature by sweating, but equine sweat has low salt and high protein (5-10 
g/L) content compared with that of humans. The horse sweat gets readily converted into 
foam and this foaming property is attributed to latherin, a surfactant protein. Even at low 
concentrations, latherin has the ability to reduce water surface tension. (Eckersall et al., 
1982, McDonald et al., 2009).  
Latherin, a 22.6kDa protein, is acidic and has a pI of 4.11 (McDonald et al., 2009). 
Latherin is composed of 228 amino acids and is exceptionally rich in leucine residues 
(Vance et al., 2014).  
25 
 
 
Figure 1-6 Cartoon diagram showing solution structure of latherin coloured red for α-helix and yellow for 
β-sheet. Image created from PDB file 3ZPM using PyMOL software (Vance et al., 2013a) 
Latherin is monomeric in solution and displays an approximately cylindrical-shaped 
structure, as determined by NMR spectroscopy (Figure 1-6). Latherin's structure consists 
of a four stranded β-sheet, two antiparallel α-helices, and two flexible, leucine-rich loops 
at one end. Like most globular proteins, latherin has a hydrophobic core and displays no 
obvious signs of being particularly amphiphilic (Vance et al., 2013a). 
 
Figure 1-7 Model showing different stages of Latherin unfolding from globular solution state to planar 
conformation state at an air : water interface. Taken from (Vance et al., 2013a). 
During interfacial association, latherin is proposed to undergo major conformational 
changes as shown in Figure 1-7. This is backed by the neutron-reflection measurements 
data, which show that latherin adsorbs at the interface forming a 1 nm thick monolayer 
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(Kennedy, 2011). Initial interfacial recognition is thought to be driven by the leucine rich 
flexible loops followed by opening of the two helices into a planar conformation, in 
which its hydrophobic core is exposed to the interface, retaining its secondary structure 
(Vance et al., 2013a). 
The conserved amino acid sequence of latherin belongs to a family of the palate, lung, 
and nasal epithelium clone (PLUNC) proteins (Kennedy, 2011). PLUNCs are the group 
of hydrophobic proteins with a pair of highly conserved cysteines and are encoded by 
sequential genes present on chromosome 20 (Gakhar et al., 2010, Bingle et al., 2004). 
PLUNCs have a role in host defence system and have been shown to be bactericidal to a 
number of bacteria including Pseudomonas aeruginosa and Mycoplasma pneumoniae 
(Di, 2011, Britto and Cohn, 2015).  
SPLUNC1, also known as Human short PLUNC, is a member of the PLUNC family 
(Garcia-Caballero et al., 2009). SPLUNC1 has been found to be present in human 
respiratory system, mammalian salivary glands and oral cavities (Tarran and Redinbo, 
2014). SPLUNC1, a 237 amino acids protein, share high leucine composition and 28% 
sequence similarity with latherin (Kennedy, 2011).  
SP-B and SP-C are the surface active proteins found in lungs but not in the upper 
respiratory tract, suggesting that a different surfactant molecule might be present. 
SPLUNC1, the most abundant secreted protein in the airways, is surface active at below 
physiological concentration in many assays (Gakhar et al., 2010).  
The recently solved X-ray crystal structure of SPLUNC 1 shows that, a SPLUNC1 
monomer consists of a central six-stranded antiparallel β-sheet, flanked by six α-helices. 
SPLUNC1 exhibits structural similarity to the Latherin and N-terminal half of BPI 
(bactericidal permeability increasing protein). Like latherin, SPLUNC1 is suggested to 
undergo a conformational change at an interface. (Garland et al., 2013). 
Mutation of four leucine residues to alanine in α-helix (α4) and/or addition of a 
disulphide mutation have inhibited bacteriostatic, surfactant, and LPS binding ability of 
the SPLUNC1 protein. Introduction of the disulphide bond is expected to restrict the 
conformational freedom of the protein and inhibited the SPLUNC1’s ability to function. 
(Walton et al., 2016). 
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1.7 Ranaspumin2  
The surface tension at an air–water interface is reduced by one of the component of 
Túngara frog foam nest, named Ranaspumin 2 (Rsn2). The remarkable features of this 
protein of being both surface active and biocompatible have formed the basis of this 
investigation. 
1.7.1 Túngara frog  
Túngara frog (Engystomops pustulosus; formerly known as Physalaemus pustulosus) 
(Figure 1-8) is one 650 of species belonging to the Leptodactylidae family (Ron et al., 
2006). This frog is very commonly found in moist, lowland sites from South and Central 
America and the Caribbean (Weigt et al., 2005). The frog’s skin has many small lesions 
(pustular), hence known as pustulosus (Ryan, 1985). 
 
Figure 1-8 Foam nest production by mating male and female Engystomops pustulosus Image courtesy of 
Alan Cooper and Malcolm Kennedy. 
Once a female has selected to mate with one of the calling males, the female frog carries 
the male in amplexus to a nesting spot, different from the calling site. There she lays a 
combination of eggs and foam precursor fluid. The male fertilises the eggs and whip up 
the fluid with their feet to make a foam nest for the eggs at the side of the pond (Ryan, 
1980). The well-studied nesting process usually takes about an hour and results in 
formation of surface floating foam nest containing 100–200 eggs (Dalgetty and Kennedy, 
2010). The foam nests are then left unattended for the remaining development from eggs 
to tadpoles. The eggs in the foam will hatch in two days giving rise to tadpoles. The 
tadpoles will survive by eating detritus in the water and will metamorphose in about 4 
weeks. If the pool dries out, the tadpoles will congregate beneath the foam, where they 
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can survive for up to five days. Tadpoles are sexually mature after a few months (Ryan, 
1985). At the point when tadpoles are ready to hatch, the foam dissolves allowing the 
tadpoles to escape into surrounding water. 
1.7.2 Foam nest 
The frog foam nest displays interesting biochemical and biophysical properties. They are 
also stable for up to 10 days (without eggs), although made up of foam is remarkable in 
itself.  It can also maintain a stable environmental temperature and act as a mini-
incubator for developing eggs and tadpoles. Being rich in carbohydrate, which naturally 
holds water, the nest resists evaporation in the tropical heat. 
These foam nests are not only mechanically stable to physical handling, but are also 
flexible enough to adapt to various conformations. They are rich in carbohydrates and 
proteins, but are not vulnerable to predation. They have also developed a mechanism for 
resistance to microbial attack, but this is not due to the foaming surfactant causing cell 
membrane disruption, as the foams are compatible with the eggs and young embryos. 
This striking feature of biocompatibility along with surface activity has suggested many 
potential biomedical applications and further research. 
 
Figure 1-9  Túngara frog foam nest with eggs seen as dots. Image courtesy of Prof Malcolm Kennedy. 
1.7.3 Foam nests components 
The túngara foam nests have a density of approximately 0.1 g/cm3. Analysis of the foam 
fluid components revealed that it is made up of 1–2 mg/ml of total protein and similar 
quantities of carbohydrate. There was an absence of fat and lipid, signifying a lack of any 
conventional small molecule surfactants. (Cooper and Kennedy, 2010). Further 
investigations resulted in discovery of six proteins, consequently named as 
“ranaspumins” (Latin: rana = frog; spuma = froth, foam). 
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Rsn1, an 11.4 kDa protein, belongs to the cystatin super family. It shows sequence 
similarity and fold similarity with the cystatins. Its exact function is unknown, but it is 
believed to function alongside Rsn2 to maintain surface activity of the bulk foam 
(Fleming et al., 2009). 
Rsn2, an 11 kDa protein, is the main surfactant protein in the foam nest (Cooper et al., 
2005). Rsn2 is discussed in detail in the next section 1.7.4. 
 
Figure 1-10 Cartoon representation of the frog foam nest components with their proposed role. (Fleming 
et al., 2009) 
Rsn 3, 4, 5 & 6 fall in the range of 18-26 kDa in weight and have sequence similarities to 
the sugar binding, lectin family of proteins. Rsn6 is a galactose binding C-type lectin; 
whereas Rsn3, 4 & 5 are fucose binding F-type “fucolectins”.  They may play a 
defensive role in protection of foam nest against microorganisms and insects like 
predators. Some of the lectins bind to target sugars on the surface of bacteria and 
decreases their ability to form aggregates. The agglutination activity of lectins has been 
shown to upset the gut of insects, perhaps discouraging them from using foam as a food 
(Cooper and Kennedy, 2010, Fleming et al., 2009). The lectin's sugar binding site is 
hypothesized to interact with the carbohydrates and provide mechanical resilience to the 
foam. 
1.7.4 Ranaspumin2 
Ranaspumin 2 (Rsn2) is a small, moderately surfactant protein secreted by female 
túngara frog (Kennedy, 2011). Rsn2 is rich in polar amino acids like lysine and aspartic 
acid, and has acidic pI of 5.16 (Fleming et al., 2009). At the C-terminus, Rsn2 displays 
unusual amino acid sequence where 6 out of its 21 aspartic acid residues are found 
consecutively, making the C-terminal region highly negatively charged. 
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Rsn2’s monomeric solution structure was solved using NMR spectroscopy (Mackenzie et 
al., 2009). The structure of Rsn2 consists of a four stranded antiparallel β-sheet and a 
kinked α-helix lying perpendicular to the β-sheet. A disulphide bond links the third and 
fourth strands of the β-sheet, while the hydrophobic N-terminus and hydrophilic C-
terminus remain mostly disordered. Rsn2 exhibits a cystatin-like fold but cystatin 
protease inhibitor activity has not been detected (Mackenzie et al., 2009).  
 
Figure 1-11 Cartoon diagram showing solution structure of Rsn2 coloured red for α-helix and yellow for 
β-sheet. Image created from PDB file 2WGO using PyMOL software (Mackenzie et al., 2009). 
Rsn2 is monomeric in solution and its structure does not obviously establish it as an 
amphipathic protein. It has been hypothesised, based on the neutron reflectivity data, that 
Rsn2 needs to undergo a conformational change to enable its interfacially active. It has 
been proposed that Rsn2 might undergo a clamshell-like opening when it approaches the 
interface (Mackenzie et al., 2009).  
 
Figure 1-12 Cartoon diagram showing the hypothesised open Rsn2 structure at the air –water interface 
and the closed globular form in solution (Mackenzie et al., 2009). 
N-terminal 
C-terminal 
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Further investigation using coarse-grained molecular dynamics simulations showed that 
interfacial adsorption of Rsn2 is a two-step process. The initial interaction with an 
interface is made by the flexible N-terminal tail, which is followed by a conformational 
change in which the helix ‘unhinges’ from the β-sheet exposing its hydrophobic core. 
Thus aligning the hydrophilic exterior in one plane, directed into the water, and retaining 
its secondary structure (Morris et al., 2016). The infrared reflection absorption 
spectroscopy (IRRAS) data and the Neutron-scattering data confirm that this is the case 
(Mackenzie et al., 2009). 
1.8 Comparison of the different surfactant proteins 
The foremost difference between the non-lipid-associated globular surfactant proteins, 
described earlier in this chapter is the diversity in their origin. Proteins with intrinsic 
surfactant activity are produced by organisms ranging from single-cell prokaryotes to 
mammals, in each case supporting a different biological function. 
Even though they have similar surfactant properties, none of the proteins show a 
similarity in their structure, nor do they have any obviously conserved amino acid 
sequence. Even the mechanism of action by which they interact at the interface is 
different, as mentioned earlier in each respective protein section.  
Although all surfactant proteins are ultimately amphipathic in nature, not all proteins 
have amphiphilic surface charge in their “native” conformation (Figure 1-13). Proteins 
like hydrophobin and BslA1 have patches of polar and non-polar regions, while Rsn2 and 
latherin have predominantly polar surfaces similar to the majority of globular proteins 
(Hakanpää et al., 2004, Mackenzie et al., 2009, Vance et al., 2013a). The later rely on 
their ability to undergo conformational change to expose the core hydrophobic residues 
to interact at the interface (Mackenzie et al., 2009, Vance et al., 2013a). In contrast 
hydrophobin and BslA1 rely on their ability to generate a surface active film via 
intermolecular association (Meister et al., 2016, Hobley et al., 2013b). Unlike 
hydrophobin, BslA1 also undergoes a small conformational change in the cap region to 
make hydrophobic interactions (Hobley et al., 2015).  
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Figure 1-13 A comparison of the surfactant proteins hydrophobin II (A) and BslA1 (B) is shown. The 
cartoon figures (A1 and B1) represent the structure of each protein with α-helices shown in red, β-strands 
in yellow and loops in green. The surface charge of the proteins are represented in figures (A2, A3, B2, 
B3) by red for negative electrostatic potential, blue for positive and grey for neutral, where the panels 2 
and 3 show opposite faces of proteins. All the surface charge figures are contoured to same range of 
potentials (-80 to + 80) and the proteins are shown at the same scale. 
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Figure 1-14 A comparison of the surfactant protein latherin  (C) and Rsn2 (D) is shown. The cartoon 
figures (C1 and D1) represent the structure of each protein with α-helices shown in red, β-strands in 
yellow and loops in green. The surface charge of the proteins are represented in figures (C2, C3, D2, D3) 
by red for negative electrostatic potential, blue for positive and grey for neutral, where the panels 2 and 3 
show opposite faces of proteins. All the surface charge figures are contoured to same range of potentials 
(-80 to + 80) and the proteins are shown at the same scale. 
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Among the globular surfactants, hydrophobins are the strongest surfactant followed by 
BslA1, and then by latherin and Rsn2. Rsn2 and latherin are considered moderate 
surfactant proteins. This comparison is made on the basis of the final interfacial surface 
tension obtained after the action of the surfactant proteins, which for hydrophobin is 20 
mN⋅m−1, compared to 50 mN⋅m−1 for Rsn2 (table1-2). The aim of this work is to apply 
the surfactant and biocompatible property of Rsn2, for various cell based biological 
applications.  
Surfactant protein Final Interfacial 
surface tension 
Reference 
Hydrophobin (class II) 20 mN⋅m−1 (Alexandrov et al., 2012) 
BslA1 27 mN⋅m−1 (Bonmatin et al., 1994) 
Latherin 43 mN⋅m−1 (Vance, 2012) 
Rsn2 50 mN⋅m−1 (Morris et al., 2016) 
 
Table 1-2 Final reduction in surface tension by the action of surfactant proteins. Final interfacial surface 
tension measurements for Hydrophobins, BslA1 and Rsn2 were made suing pendant drop method; while 
microtrough tensiometer was used for Latherin.  Note – The final interfacial surface tension value gives an 
estimate for comparison among the surfactant proteins. The method used, along with time and protein 
concentration required to reduce the interfacial surface tension are not the same in every instance, so 
some minor difference is expected in the values . 
1.9 Aims 
The aim of this project was to use the unique features of Rsn2 protein to develop various 
biotechnological applications with a particular focus on cell engineering.  
The project developed along four main themes: approaches for cell patterning by 
controlling cell adhesion on surfaces that do not otherwise support cell adhesion; analysis 
of bone cell growth on surfaces coated with integrin binding sequence-Rsn2 fusion 
proteins; production of  Rsn2 stabilised droplet emulsions; and, a method to solubilise 
C60 (Fullerene). These will each be described in the subsequent chapters. 
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2 Cell patterning with Rsn2  
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2.1 Introduction 
For many tissue engineering approaches, cells are seeded into scaffolds that support 
subsequent tissue formation. A range of scaffolds that have desirable mechanical 
properties are available, but most of them are hydrophobic (non-wettable) polymer to 
which cells have difficulty attaching (Chan and Leong, 2008a). Thus there is a need to 
engineer a material surface to promote cell adhesion and enhance tissue function.  
The factors that influence cell-adhesiveness to the surface materials are of significant 
interest in the bioengineering of complex tissues. Many approaches have been tested, 
including modifying the chemical and topographical properties of the surfaces to enhance 
cell adhesion. These alterations in the physicochemical properties of the material surface 
will influence protein adsorption and thereby cell adhesion (Welle et al., 2014). Cell 
adhesion is mediated by cell adhesion molecules like cadherins and integrins. 
Modification of the material surface to enhance cell adhesion is described in detail in 
section 3.1 of this thesis. 
The interaction of living cells with a scaffold material is mediated through the integrin 
receptors, which will interact with the protein film deposited on the material surface. 
This provides an opportunity to guide cell attachment and development by controlling 
the pattern of protein deposition. Cell patterning provides a useful tool for research in 
overcoming the limitation of conventional cell culture techniques. Even cell patterning 
has some limitations, such as having only two dimensions, though research is underway 
to develop 3D scaffolds, but it brings us a step closer to tissue engineering.  
Patterns of proteins and cells have been generated using photolithographic, soft 
lithographic, micro-contact printing, Inkjet printing and dip coating techniques. A brief 
overview of these widely used patterning techniques is follows. 
Kleinfeld and colleagues used the photolithography process from electronics and created 
new methods for cell patterning (Kam et al., 2013). Photolithography works on the 
principle that when radiation is applied to the photoresist material layered on a master, 
only the photoresist to which radiation is applied becomes soluble in particular solvents, 
which depends on the type of the photoresist used. Thus a pattern is developed by 
washing the soluble photoresist with a solvent and leaving the insoluble photoresist 
intact. This method can be used to create patterns on substrate with features at the 
precision of submicron level (less than 100 nm) (Nie and Kumacheva, 2008). This 
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method is one of the most popular methods for patterning cells and proteins. Although 
this method is highly reproducible, it requires specialised equipment and clean room 
facilities for producing the substrate along with being laborious and expensive. Soft 
lithography, a modified version of lithography, is a versatile technique for generating 
patterns of proteins and cells. 
Soft lithography, initially developed by Whitesides and colleagues, are so called because 
they involve production of a stamp, mould or mask made from a soft elastomeric 
material by means of lithography. (Qin et al., 2010a). This elastomeric stamp can be used 
to copy patterns on to another material through surface direct printing, position limited 
adsorption, or masking. Typically poly(dimethylsiloxane) (PDMS) is used as a soft 
elastomeric material of choice. This technique overcomes many limitations of 
photolithography and offer some advantages such as being inexpensive, being easy to 
develop, having the ability to pattern a variety of substrates, and not requiring specialized 
equipment or chemicals (Ratner and Bryant, 2004). However, most of the soft 
lithography techniques are restricted to substrates such as gold, silver, or silicon, whereas 
for many applications, other substrates such as polymers are more desirable. To 
overcome this, micro-contact printing (µCP) techniques have been developed. 
In the µCP approach, different patterns can be generated on a variety of substrate 
surfaces (James et al., 1996), including patterned self assembled monolayers (SAMs) 
(Kumar and Whitesides, 1993). µCP has been used to generate patterns on different 
substrates and functionalised them using  proteins, DNA  as well as the organic thiol 
solutions used for gold functionalisation (Bernard et al., 2000, Hui et al., 2002)  
Another method for delivering fine patterns using liquid "inks" is inkjet printing. In this 
method, cell-adhesive materials are used instead of ink to produce a patterned substrate. 
Inkjet printers are an alternative patterning technology that produces  droplets of tens of 
microns in diameter, which are deposited onto a material surface, and develop into a 
pattern when the solvent evaporates (Cui et al., 2014, Cui et al., 2012)  (Nie and 
Kumacheva, 2008). The inkjet printing technique offers advantages of being cost 
effective and, unlike for soft lithography, it is easy to change the pattern from one printed 
item to another at a resolution of 1,400 dpi in 3D (Cui et al., 2014) 
Some other proteins and peptides, like hydrophobins and polydopamine (PDA), have 
been used for cell patterning. Like Rsn2, hydrophobins and PDA can be used to make 
proteinaceous coatings on the polymer surface and render them biocompatible (Janssen 
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et al., 2002a, Huang et al., 2016). Thus different proteins have been tested in the past to 
promote cell adhesion. This chapter will focus on the development of patterned scaffolds 
using a naturally surfactant protein, Rsn2. 
As described earlier in section 1.7.4, Rsn2 was identified as one of the foam nest 
components of the Túngara frog (Fleming et al., 2009). The foam protein from these 
nests showed significant surfactant properties while retaining biocompatibility with 
fertilized eggs, sperms and young embryos(Cooper and Kennedy, 2010). It is unusual for 
a protein to be highly surfactant and this feature of the Rsn2 protein was used to develop 
approaches to pattern hydrophobic surfaces thereby directing cell adhesion. 
 It was hypothesized that the use of Rsn2 was expected to be beneficial compared to 
other patterning techniques because of the removal of any need for chemical treatment.  
Cell patterning is a process to control the spatial position of the cells onto a substrate. In 
this chapter, the cell patterning is obtained by dip coating Rsn2 protein onto the surface 
and seeding it with cells. Strictly speaking, this is more of controlling cell adhesion onto 
a large surface area and not forming fine cell patterning in microns. 
2.2 Aim  
The aim of the project was to develop a set of tools that allow cell patterning on a range 
of hydrophobic scaffolds. 
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2.3 Methods and Materials 
2.3.1 Rsn2 production 
Recombinant Rsn2 and iLOVRsn2 expression constructs (generated by Dr S.J. Vance) 
were utilised for Rsn2 and iLOVRsn2 expression and purification. 
2.3.1.1 Protein Expression 
Rsn2 and iLOVRsn2 were expressed using Novagen’s pET28 expression system. The 
strong bacteriophage T7 promoter has the control of the gene cloned into a pET plasmid. 
This has an advantage over host transcription as T7 RNA polymerase is selective and 
much more active as compared to its host counterpart. Basal expression is inhibited by a 
Lac repressor binding sequence incorporated in the promoter assisted by expression of 
lac repressor protein. This control element regulates expression of both the target gene 
and the T7 polymerase gene integrated into the host genome. Once induced using the 
lactose analog, isopropyl β-D-1-thiogalactopyranoside (IPTG), almost all of the host 
cell’s resources are transferred towards the target gene expression. As a result, high levels 
of expression of the desired protein can be achieved in just a few hours after induction. 
Also, it is possible to modulate the expression level by varying the concentration of 
IPTG, which can help to optimise the soluble yield of target protein (Rosano and 
Ceccarelli, 2014). 
2.3.1.1.1 Transformation 
Competent E.Coli. were transformed with a pET28(b) based, kanamycin resistant 
expression vector carrying the coding sequence for Rsn2 expressed as a fusion protein 
with a thrombin cleavable N-terminal 6-His tag. Plasmid was incubated with chemically 
competent BL21 (DE3) cells (Novagen) for 30 minutes on ice. The mixture was then 
heat-shocked at 42○C for 30 seconds and immediately returned to ice. Transformed cells 
were grown in SOC media for 1 hour and were spread on LB plates containing 
kanamycin. Plates were then incubated overnight at 37○C. 
2.3.1.1.2 Protein Production 
Overnight cultures were set up and used at 1:100 dilutions to seed 8  500 mL LB broth 
in 2 L conical flasks. The 500 mL cultures were incubated with shaking (200 rpm) at 
37°C until the OD600 reached 0.6-0.8. The cells were then induced using IPTG at a final 
concentration of 1 mM and were incubated for a further 3 hrs. Cells were harvested by 
centrifugation at 4°C for 25 minutes. The supernatant was discarded and the cells were 
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re-suspended in 20 mL of binding buffer (20 mM Tris, 500 mM NaCl, 5 mM Imidazole, 
pH 8) for 4 L of culture. 
2.3.1.2 Protein Purification 
The process of Rsn2 and iLOVRsn2 purification can be divided into three key steps: cell 
lysis and insoluble cell debris removal; Ni2+ -affinity chromatography; and analysis using 
SDS-PAGE. 
2.3.1.2.1 Cell Lysis and Insoluble Cell Debris Removal 
Two methods were assessed for cell lysis, namely detergent lysis and sonication. The test 
expression using detergent solution (Bugbuster, Novagen) for cell lysis resulted in a 
greater proportion of target protein being seen in the insoluble fraction. Thus sonication 
was used for cell lysis in large scale expressions, which gave less insoluble target 
protein. A plausible explanation for the difference between the lysis methods is that the 
amphiphilic nature of the detergent causes denaturation of protein resulting in 
aggregation. Thus sonication was deemed acceptable for cell lysis.   
For sonication, 500 U Benzonase (Novagen) and an EDTA free protease inhibitor tablet 
(Roche) were added to the re-suspended bacterial pellets and sonicated on ice at 10 
microns amplitude for 15 cycles of 30 seconds on and 30 seconds off. 
Following sonication, insoluble cell debris was removed by high speed centrifugation at 
40,000 g for 25 minutes and careful decanting of the supernatant. The supernatant was 
filtered using 0.2 μm filter leaving a solution containing the protein of interest along with 
the remaining soluble cell components. 
2.3.1.2.2 Ni2+-Affinity Chromatography 
Rsn2 and iLOVRsn2 fusion proteins were expressed with six consecutive histidine 
residues at the N-terminus and purified using metal chelation chromatography (Ni2+ 
bound within a nitrilotriacetic acid (Ni2+-NTA) column). Ni2+-affinity chromatography 
was chosen for protein purification because of its simplicity and reliability (Bornhorst 
and Falke, 2000). 
The cleared lysate was passed through an Econo pack (BioRad) column loaded with 5 x 
ml bed of Ni-NTA His-bind Super flow (Novagen), previously equilibrated with binding 
buffer. The flow through was collected and the column washed with binding buffer 
containing 5 mM imidazole. The poly-histidine fusion tag (His-tag) protein sequence 
binds to Ni2+ ions, which are immobilized on the Ni-NTA Resin (Bornhorst and Falke, 
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2000, Khan et al., 2006). Non-specific binding via electrostatic interactions was inhibited 
by the presence of NaCl in the buffer. The column was then washed with wash buffer  
(20 mM Tris, 500 mM NaCl, 25 mM Imidazole, pH 8) containing 25 mM imidazole to 
remove weakly bound proteins. This was followed by elution in buffer containing a high 
concentration of imidazole (300 mM), which displaces the bound histidines. Finally a 1 
M imidazole wash was applied to ensure that the column was clean before re-
equilibration in binding buffer. 
2.3.1.2.3 SDS-PAGE  
The success of the protein purification was determined by SDS-PAGE (sodium dodecyl 
sulphate polyacrylamide gel electrophoresis). The underlying principle is to use an 
electric field to displace charged protein-SDS complexes through a porous matrix and 
separating them on the basis of their molecular weight.  
The lysate and flow through samples were diluted to a final volume (in μl) which was 
150 times the OD600 at harvest to ensure even loading of the gel. The samples were 
mixed with SDS-PAGE loading buffer and then heated at 85○C for ten minutes before 
loading on the gel. SDS was added to mask protein intrinsic charge and to impart 
negative charge to the protein, generating unfolded proteins into linear chain depending 
on its size. Glycerol was added to render density to the loading sample and the 
bromophenol blue to track the electrophoresis progress of the gel. Upon application of 
electric voltage, the proteins will get separated based on their size by a sieving 
mechanism. Gels were then stained with Coomassie Brilliant Blue Stain and destained in 
‘Coomassie Destain Solution’ (70% distilled H2O, 15% CH3OH and 15% CH3COOH) to 
visualise the protein bands. 
2.3.2 Pendant drop tensiometry  
The purified Rsn2 proteins were assessed for functionality by evaluating their surface 
activity by pendant drop measurement. Rsn2, being a surfactant protein, should act on 
the air-water/air-oil interface and reduce the surface tension and so affect the shape of the 
pendant shaped droplet formed during the experiment.  
Pendant drop experiments were performed on a Kr¨uss EasyDrop tensiometer. Rsn2 was 
diluted in MilliQ water and immediately placed in a syringe with a needle diameter of 
1.83 mm. Images of the pendant drop were captured by a CCD camera and their shapes 
fitted to the Young-Laplace equation using  Kr¨uss software to determine the interfacial 
tension. 
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2.3.3 Wettability  
The effect on the wettability of surfaces coated with Rsn2 was assessed using an 
environmental scanning electron microscope (ESEM) by observing the formation of 
microscopic water droplets on samples in an environment held at 100% relative humidity 
(RH).  
 Glass coverslips to be used were thoroughly cleaned with concentrated nitric acid, rinsed 
twice with distilled water and dried overnight. Hydrophobic surfaces were prepared by 
dipping only half of the coverslip in silanizing reagent (dimethyldichlorosilane) for 5 
minutes and again drying overnight. Only the silanized half of the coverslip was dipped 
in 1 mg/ml of Rsn2. Any excess Rsn2 was removed by dipping in distilled water twice 
before subjecting to ESEM. 
Then the images of Rsn2 coated and non-coated surface were taken after 30, 70 &120 
minutes. The obtained ESEM images were subjected to ImageJ analysis to calculate the 
percentage of the area covered by water droplets on coated and non-coated surfaces.  
2.3.4 Contact Angle  
Contact angle measurements were performed by dip coating half of a clean glass slide 
with protein sample (1 mg/ml). Any excess Rsn2 was removed by dipping in distilled 
water twice and air drying before subjecting to water contact angle measurements. Then 
water drops of uniform volumes of 20 μL were transferred onto a half coated glass slide 
and the contact angle of each droplet measured at room temperature. Contact angle 
measurements were carried out using the sessile drop technique with a KSV CAM 100 
contact angle goniometer (KSV Instruments, USA) on Rsn2 coated and non-coated 
surfaces. High contrast images of static water droplets were recorded and CAM 100 
software was used to determine the water contact angle.  
Similarly to assess relative hydrophobicity, water contact angle was measured on a range 
of materials including silanized glass, polycarbonate (PC), polytetrafluoroethylene 
(PTFE), poly(methyl methacrylate) (PMMA), Nylon, polystyrene (PS), polypropylene 
(PP), ACLAR and polydimethylsiloxane (PDMS). Contact angle measurements were 
made on the Rsn2 coated and non-coated surfaces for each material. Mean and standard 
deviation were calculated using data from three set of experiments. 
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2.3.5 Persistence 
Fluorescence from the FMN of the iLOV fusion protein in iLOVRsn2 was used to check 
the longevity of Rsn2 coating on a range of hydrophobic surfaces. All the surfaces used 
were cleaned with 70% ethanol and then rising twice with water. Thereafter fluorescent 
iLOV-Rsn2 protein (1 mg/ml) was applied onto each material surface and incubated for 
one minute. Excess protein was removed by extensive, rapid rinsing with water. The 
protein-coated material was incubated in PBS at 37⁰C and fluorescence microscopy was 
carried out every day for 10 days.   The range of materials tested in this experiment were 
– ACLAR (Agar scientific Ltd.), silanized glass, Nescofilm™, nylon (Good Fellow, 
Ltd.), polycarbonate (PC) (Good Fellow, Ltd.), polydimethylsiloxane (PDMS), 
Polymethyl methacrylate (PMMA) (Good Fellow, Ltd.), polypropylene (PP) (Good 
Fellow, Ltd.) and polystyrene (PS) (Good Fellow, Ltd.). 
To avoid the loss of fluorescence signal due to photobleaching, optimisation was done in 
order to find out the duration of exposure after which bleaching effects may occur. Once 
determined, all the samples were exposed under blue light for the same duration (400 
mm, which is less than the time required for photobleaching), while keeping numerical 
aperture constant. 
 To calculate and eliminate the effects of fluctuations in the intensity of the light source, 
autofluorescence from the white filter paper (whatman lens cleaning tissue, GE 
healthcare) was used as a control along with neutral density filters (Zeiss). Fluorescence 
images of iLOVRsn2 coated and non-coated regions were exported to ImageJ to quantify 
the intensity of fluorescence. Obtained intensity of fluorescence were then normalised by 
dividing with the value of intensity obtained using filter-2 (% transmission = 53.6%). 
 While conducting fluorescence microscopy, background signals can affect the reliability 
and quality of the results, hence background signals were subtracted before making any 
quantifications using the formula, T (total signal) = Signal + Background. 
2.3.6 Routine cell culture  
Cell culture work was performed aseptically at room temperature using laminar flow cell 
culture hoods and cells were cultured in an incubator at 37°C under humidified 
conditions with ventilation of 5% CO2. Cells were maintained in Dulbecco's Modified 
Eagle's Medium (DMEM) (PAA Laboratories) supplemented with 10% Foetal bovine 
serum (FBS, Invitrogen) and 1% penicillin and streptomycin (Sigma) unless otherwise 
stated 
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Fibroblast cell lines (h-TERT, Lonza, USA) were seeded into a 75 cm2 (T-75) culture 
flask (BD Biosciences, San Jose, CA, USA) containing medium and incubated. After 48 
hrs in culture, the non-adherent cells were discarded and cells were fed with fresh 
medium. Medium was replaced once a week. Cells were allowed to reach 70-80% 
confluence and then the cells were passaged. Briefly, the culture medium was aspirated 
and the cells washed in HEPES saline following which 5 ml trypsin was added (PAA 
Laboratories) and incubated at 37°C for 5 minutes. The action of trypsination was 
neutralised by adding 5 ml medium and a cell count was performed using a Neuber 
chamber. The cells were then seeded in a 150 cm2 culture flask (BD Biosciences, San 
Jose, CA, USA) for sub culture. 
2.3.7 Fabrication of PDMS 
Polydimethylsiloxane (PDMS) was made by properly mixing PDMS 184 polymer 
solution 90% (Wt/Wt) (Sylgard® 184 Silicone Elastomer, Dow Corning, UK) with  10% 
(Wt/Wt) curing agent.  The mixture was kept under vacuum for 30 minutes to de-gas it 
and remove any bubbles. The mixture was then transferred to a sterile petri dish and left 
to set overnight at 180⁰C. Solidified PDMS was treated with n-pentane to remove 
unbound DMS in order to remove the capacity for self-healing of the PDMS surface thus 
avoiding peeling off of the protein coat (Lee et al., 2003). PDMS casts were sterilised by 
washing in 70% alcohol followed by rinsing in sterile water twice. PDMS casts were 
then dried using sterile-filtered nitrogen gas in preparation for cell patterning 
experiments.  
2.3.8 Cell Patterning 
Cell culture substrates made of PDMS, PS and glass were rinsed with 70% alcohol to 
sterilise them and dried. Glass was further subjected to salinization, by adding a 
organofunctional alkoxysilane molecules to the surface of the glass, which will increase 
its hydrophobicity and cell selectivity. A pattern was developed on each substrate by dip 
coating half of each substrate with Rsn2 at a concentration of 1 mg/ml for 1 minute 
before rinsing with sterile PBS. A confluent flask of h-TERT cells was trypsinised and 
used to seed the substrates homogenously. Cells were incubated at 37°C for up to 72 hrs 
before fixing them with 4% formaldehyde and stained with coomassie blue. Cell density 
and cell surface area measurements were performed using ImageJ software. Paired T-test 
was used for significance analysis. 
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2.3.9 Fluorescence staining 
Samples were washed with PBS and fixed with 10% v/v formaldehyde/PBS for 15 
minutes at 37°C. Cells patterned were stained with 4', 6-diamidino-2-phenylindole 
(DAPI) mountant and visualised using Olympus fluorescence microscope at 10X 
magnification.  
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2.4 Results  
2.4.1 Rsn2 and iLOVRsn2 production  
Recombinant His-tagged Rsn2 proteins were produced in E. coli and purified to a high 
degree by Ni2+-affinity chromatography as seen in Figure 2-1. A good yield for Rsn2 
(19.23 mg/L) and for iLOVRsn2 (7.5 mg/L) were obtained.  A right size band appeared 
for both the protein as observed by SDS-PAGE. 
 
Figure 2-1 SDS PAGE of Rsn2 nickel affinity purification, (1) Cell lysate flow through; washes with 
(2)binding buffer and (3) wash buffer; (4 & 5) Elutions; (6) 1M imidazole and (M) Marker (NEB pre 
stained protein ladder). Mw of iLOVRsn2 is ~ 14 KDa, which is where the band is obtained in elution 
fraction. 
 
 
Figure 2-2 SDS PAGE of iLOVRsn2 Nickle affinity purification (1) Cell lysate flow through; washes with 
(2)binding buffer and (3) wash buffer; (4 & 5) Elutions; (6) 1M imidazole and (M) Marker (NEB pre 
stained protein ladder). Mw of iLOVRsn2 is ~ 27 KDa, which is where the band is obtained in elution 
fraction. 
2.4.2 Pendant drop tensiometry  
Pendant drop experiments were performed to explore the behaviour of Rsn2 at an 
air/water and oil/water interface. A droplet of Rsn2 (1.3 mg/ml) in low salt buffer was 
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formed in trioctanoyl glycerol to produce an oil-water interface. The obtained droplet 
was fitted using the Young-Laplace equation to estimate the surface tension,  
 
where Δp stands for the pressure difference, r1 and r2 for the radii of curvature of the 
surface and the interfacial tension is calculated (KRUSS).  
Rsn2 reduced the interfacial surface tension from the initial interfacial surface tension of 
72 mN/m to 50 mN/m (Figure 2-4 A). The control, the interfacial surface tension of a 
droplet of buffer alone formed in trioctanoyl glycerol, also was 72 mN/m. This result of 
finial interfacial surface tension is in close agreement with measurements of surface 
tension depression by Rsn2 measured by micro trough tensiometry (Vance, 2012).  
To gain further insight into Rsn2’s behaviour at the interface, the droplet was compressed 
after a curing time of 10 minutes. It was observed that upon compression of the droplet, 
transient wrinkles were formed (Figure 2-3), indicating that Rsn2 forms a film at the 
interface. The wrinkles in the film completely relaxed after 5 seconds indicating that this 
process of film formation is fully reversible. The observations of depression of the 
surface tension is similar to other surfactant protein such as hydrophobin (Szilvay et al., 
2007) and BslA (Hobley et al., 2013a), confirming recombinant Rsn2 is a functional 
surfactant protein.  Interestingly, the rapid resolution of the wrinkes for Rsn2 is in 
contrast to hydrophobins and BslA, whose wrinkles did not relax after 10 minutes 
(Bromley et al., 2015).  
Wrinkles are a sign of hysteresis that is due to the interfacial structures being 
thermodynamically stable and therefore long-lived. This is because of the interactions 
between the surfactant molecules at the surface and the energy barrier that must be 
overcome to drive them back into bulk solution. The difference in wrinkle characteristics 
between Rsn2 and hydrophobins can be attributed to the way the individual protein 
interacts at the interface. Rsn2, a monomer in solution, undergoes a conformational 
change upon interaction with the interface where it does not appear to act cooperatively 
with its neighbouring Rsn2 monomers. The hydrophobins, dimers or tetramers in 
solution, form a homogeneous film at the interface by interacting with neighbouring 
molecules using H-bond together making continuous β-sheets. Thus upon retraction of 
the droplet in pendant drop method, individual Rsn2 molecules can undergo 
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conformational change in to a globular shape monomer that can re-dissolve into the bulk 
solution and thus the interfacial surface area can decrease rapidly allowing the wrinkles 
to relax. In contrast, the hydrophobins are arranged in a relatively rigid, cooperative 
conformation such that they do not go back into the solution rapidly upon retraction and 
the wrinkles remain stable. 
A 
 
B 
 
Figure 2-3 Rsn2 film relaxation at trioctanoyl glycerol oil/water interface. (A) Droplet of 1.3 mg/ml Rsn2 
before compression. (B) After surface compression induced by reducing the drop’s volume. Large wrinkles 
or folds appear in the surface layer which rapidly relax. 
2.4.3 Wettability 
Wettability experiments were performed to investigate Rsn2 ability to coat surfaces and 
make them hydrophilic or wettable. In each ESEM experiment, half of a coverslip was 
coated with Rsn2 and subjected to ESEM.  At 100% RH, water droplets started to form 
on both the parts of the coverslip. The percentage area covered by condensation was 
calculated for Rsn2 coated and uncoated regions and compared. After 30 minutes 
incubation, droplets started to develop on protein coated regions only and the number 
and size of the droplets had increased by 70 minutes. Only after 120 minutes incubation, 
were droplets formed on non-coated regions. At the 120 minute time point, Rsn2 coated 
regions showed significantly higher area of condensation compared with non-coated 
regions. 
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A 
 
 
 
 
 
 
B 
 
Figure 2-4 Formation of water droplets on a coverslip having coated & non-coated Rsn2 regions 
subjected to ESEM at 100% RH, where (A) is a representative ESEM images of water droplet formation 
on Rsn2 coated & non-coated region after 120 minutes and (B) is a graphical representation of 
condensation area of Rsn2 coated vs. non-coated surface. 
2.4.4 Contact angle 
Investigations were made to assess the range of surfaces that Rsn2 can coat, using 
contact angle measurements. Rsn2, being a surfactant protein, should reduce the surface 
tension of the droplet, thereby reducing the contact angle of the droplet. 
Except glass, all the materials chosen are hydrophobic, as shown by angle of contact of a 
pure water droplet on their uncoated surface, and display a range of hydrophobicities. 
When an Rsn2 coat was applied, water droplets spread out, decreasing the angle of 
contact indicating decreased hydrophobicity. 
Upon coating with Rsn2, the wettability of all the material surfaces improves noticeably, 
except for the PTFE in which nearly no change in the contact angle was observed 
between coated and non-coated surface. The difference in the change of contact angle 
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among different surfaces could be attributed to the initial loading of Rsn2, which is 
dependent on the nature of the surfaces and could be different for different substrates.  
The contact angle result shows that the initial loading of Rsn2 was higher on to PC, 
Glass, PP, ACLAR, PS, PMMA and Nylon. Consequently, an increase in wettability is 
observed the most in case of PC, followed by Glass and PP, while the least change in 
wettability was observed in PTFE and PDMS.  
In case of PDMS, the difference in contact angle is not much, suggesting low initial 
loading of Rsn2 on PDMS surface. But the result of persistence experiment suggests that 
the initial loading of Rsn2 is very decent in case of PDMS. This difference in initial 
loading of Rsn2 on different substrates could be due to difference in the method used for 
measuring it. In the case of measurement of fluorescence, auto-fluorescence was not 
taken into account. This auto-fluorescence might have added to the initial loading of 
Rsn2 and therefore, the reading between CA and persistence experiments vary. Hence it 
may be said that measurement of fluorescence alone may not be reliable for concluding 
the initial loading of Rsn2 on different substrates. 
Thus contact angle measurement shows that presence of Rsn2 makes the surfaces more 
hydrophilic for range of hydrophobic materials.  
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Figure 2-5 The contact angle of water on Rsn2 coated and non-coated regions after dip coating with the 
Rsn2 protein solution (1mg/ml). A typical example of a water droplet on coated surface (A) and non-
coated surface (B) is shown. (C) Graphical representation of the contact angle of water measured on the 
range of hydrophobic materials. Mean values were used to plot graph with bars representing the standard 
deviation (n=3).  
2.4.5 Persistence 
The three dimensional structure of Rsn2 in solution reveals that it has a hydrophobic 
interior and hydrophilic exterior (Mackenzie et al., 2009). Here the authors also discuss 
that once Rsn2 comes to the air water interface, it is believed to open up to expose it 
hydrophobic core to the air leaving the hydrophilic exterior to interact with water. By the 
same principle it is expected that, when applied to hydrophobic surfaces, Rsn2 should 
unfold to make hydrophobic interactions with hydrophobic surfaces, thus resulting in 
coating the hydrophobic surface with Rsn2 protein. Investigations were made to test 
whether Rsn2 adheres to a surface and how long it stays there, using a fusion protein 
construct of Rsn2 with a small fluorescent protein fusion partner (improved Light 
Oxygen Voltage, iLOV, developed by Prof Christie of University of Glasgow (Christie et 
al., 2012)). This will impart fluorescence to the Rsn2 coating and the presence or absence 
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of coating can be detected using fluorescence microscopy. Controls, as mentioned in 
section 2.3.5 were used to increase the quality and reliability of quantification of 
fluorescence intensity, which directly correlates to the loading of iLOVRsn2 protein. It is 
worth noting that Flavin mononucleotide (FMN), the molecule imparting fluorescence, is 
not covalently bound to iLOV and therefore it is possibility that FMN could slowly leach 
out with longer lasting experiments.  
Results after 1 day of initial coating show that the initial loading of iLOVRsn2 is highest 
on Nylon followed by PDMS and ACLAR, while the least loading is observed for 
Nescofilm. After 5 and10 days of coating, the initial loading of iLOVRsn2 is gradually 
lost from Nylon, while it remains stable on PDMS and ACLAR. Results show that 
fluorescence intensity of iLOVRsn2 coating remains stable over the 10 days of 
incubation for ACLAR, Glass, Nescofilm, PC, PDMS, PP and PS types of material, while 
the intensity gradually decreases for Nylon and PMMA. Although the intensity of 
fluorescence measured on Nylon coating decreases after 10 days, it is still higher 
compared to the intensities of other material. This shows that PDMS and ACLAR are 
good choices of material for Rsn2 based application from the perspective of high and 
stable levels of loading. 
 
 
 
 
 
 
 
53 
 
                   
 
Figure 2-6 The persistence of Rsn2 coating on hydrophobic material. Persistence was measured by 
quantifying intensity of fluorescence from iLOVRsn2 (1mg/ml) coated protein. (A) A typical fluorescent 
image of the edge of Rsn2 droplet on PCL (B) Graphical representation of the persistence of Rsn2 coating 
on the range of hydrophobic materials tested. Measurements were recorded after 1, 5 and 10 days of 
incubation in PBS at 37⁰C. Mean values were used to plot graph with bars representing the standard 
deviation (n=3).  
2.4.6 Cell patterning  
In order to discover whether Rsn2 coated surfaces have the potential to pattern cells, PS 
substrates were dip coated with Rsn2 and seeded with fibroblasts. After 24 hours in 
culture, cells preferentially adhered to Rsn2 coated regions and exhibited a well-spread 
morphology compared to those cells adhered to the non-coated region. Bare PS 
substrates did not support cell growth and development with only a few undeveloped 
somata observed after 24 hours. Cells remained pattern compliant on Rsn2 treated PS 
surface after 72 hours in culture. Cells on Rsn2 treated PS surface exhibited cell growth 
and division compared to non-coated regions for the observed period of 72 hours as seen 
B 
         A 
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in Figure 2-7. Cells cultured on Rsn2 coated PS shows significantly higher cell density 
compared to uncoated surfaces. 
 
Figure 2-7 Representative light microscopy image taken at the boundary between Rsn2 coated and non-
coated regions of the patterned h-Terts cells cultured on PS after (A) 24 hrs and (B) 72 hrs 
A 
B 
 
Figure 2-8 Comparison of coated and non-coted regions of h-Terts cells cultured on Rsn2 coated PS for 
(A) Cell density after 24 hours & 72 hours of incubation and (B) surface area per cell after 24 hours of 
incubation.  
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From the contact angle and persistence experiments, it was known that Rsn2 can coat a 
range of surfaces and from cell patterning experiments it was known that Rsn2 coating 
can support cell adhseion and cell patterning. The next step was to investigate the 
possibility of obtaining patterned cells on a range of material surfaces. For this PDMS, 
silanized glass and PS materials were used along with hTert cell lines. Even though Rsn2 
can adsorb on range of surfaces, only PDMS, glass and PS were selected for cell pattern 
screening because PDMS, PS and glass are extensively used for culturing different types 
of cells because of their optical transparency, low cost and easy availability or easy 
fabrication. Even though PS and glass are traditionally used for cell culture, PDMS gives 
an added advantage of biocompatibility, low toxicity and compatibility with soft 
lithography for making finer patterns (Lee et al., 2004). So PDMS was also selected.   
Silanized glass and PDMS were used along with untreated hydrophobic PS to investigate 
the posibility of obtaining cell patterning on different types of substrates. Pattern 
compliant cells were obatined on all the three types of substrates as seen in the Figure 
2-9.  
   
Figure 2-9 Scanned image of coomassie blue stained pattern compliant h-Terts cells cultured on Rsn2 
coated and non-coted regions of (A) silanised glass, (B) PS & (C)PDMS after 72 hours of incuabtion.  
 
Figure 2-10 A montage fluorescence image taken on the edge of the Rsn2 coated and non-coated region 
seeded with h-Tert cells and stained with dapi, for the nucleus of cells. The image clearly shows that cell 
preferentially adhered to the Rsn2 coated region. 
A B C 
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2.5 Discussion 
From previous studies it was already known that Rsn2 is a surfactant protein, this work 
has reinforced those findings using the water contact angle; ESEM & pendent drop 
method and has shown that Rsn2 can be very effective for cell patterning on a range of 
hydrophobic surfaces. Literature reveals that most of the cell patterning technique 
developed have material dependency and is only suitable for limited number of surfaces, 
for example photolithography can only be used for SiO2 based materials (Hughes et al., 
2014).  The obtained results of cell patterning Figure 2-7 experiment suggest that Rsn2 
has material independency and can be used to modify a range of material surface to 
generate patterned cells. Thus the use of Rsn2 provides an important advantage of not 
limiting the cell patterning application to the type of substrate.  
 
In the study conducted by Lussi et al., where the comparison is made on the long-term 
stability of cellular patterns developed with the PEG-graft patterning techniques. The 
conclusion was that the differences in the pattern compliancy of cells were due to the 
different interactions between the patterned substrate, the PEG graft and the serum 
containing cellular medium (Lussi et al., 2006). In contrast to the finding of Lussi et al., 
Rsn2 based patterned cells were pattern compliant in all three different substrates tested 
for 72 hours Figure 2-9.  
Rsn2 only coats the surface and that coating does not require any specific surface 
chemistry but rely on physical parameter, thereby widening the scale of application 
(Straley and Heilshorn, 2009, Janssen et al., 2002b). The surface application of Rsn2 can 
be achieved by a simple dip coating technique. Most cell patterning methodologies 
require specialised instruments and facilities to pattern cells. For example, 
special/specific chemical and/or physical treatment is needed for soft lithography to 
develop PDMS mould (Qin et al., 2010b). This study has shown that obtaining pattern 
compliant cell using Rsn2 is not complicated, as it involves adsorption of protein onto 
material surfaces at normal room temperature and there is no need of specialised 
instrumental set up required for its application.  
The use of Rsn2 gives an added advantage of retaining the mechanical properties of the 
selected material and being a protein it can be degraded into non-cytotoxic fragments 
(Straley and Heilshorn, 2009). Additionally, the requirement of specialized instruments 
and chemicals needed for direct patterning methods, like bioprinting, can incur higher 
cost and time compared to using Rsn2 for cell patterning (Gesellchen et al., 2014). More 
over Rsn2 production requires minimal protein expression facilities and its production 
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can be easily scaled up for achieving high yield. The surplus Rsn2 can also be easily and 
safely stored for long term use. To summarise, Rsn2 offers may advantages for its 
application in cell patterning. 
One potential hurdle of using Rsn2 in therapeutic application is that Rsn2 being a foreign 
protein may trigger an immune response and therefore it may be a challenge to use Rsn2 
protein for biomedical applications in future. Although other proteins, like hydrophobins 
(Scholtmeijer et al., 2002) and polydopamine (Ku et al., 2010), used in cell patterning 
may also be immunogenic. To counter this situation, there is a possibility of using 
SPLUNC1 protein, more information in section 1.6. SPLUNC1, a human surfactant 
protein, like Latherin is proposed to undergoes a conformational change at an interface 
and can be used to coat surfaces for cell patterning (Vance et al., 2013b). 
Moreover, the method of applying Rsn2 by dip coating suited to generate total coverage 
of a substrate or large scale patterns with low precision. Finer patterning could be 
advantageous for controlling cell placement, which could be achieved by using Rsn2 as 
an ink for nano or micro contact printing. Prof Dalby of University of Glasgow have 
demonstrated the effects of nanotopography on stem cells (Dalby et al., 2014). Similarly, 
the nano-level features developed by coating Rsn2 using nano-contact printing can be 
used for co-culture patterning using specific integrin binding sequences (Table 3-1)  
To conclude, the cell patterning method developed by using Rsn2 offers advantage of 
simple application technique, which will result in a persistent protein coat on a range of 
hydrophobic surfaces.  
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3 Functionalisation of PDMS with IBS-Rsn2  
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3.1 Introduction  
Cell-based tissue engineering focuses on the restoration of a functional tissue in the hope 
of answering the currently unmet medical need of wound healing of complex tissues. For 
various tissue engineering approaches, cells are implanted into scaffolds capable of 
supporting three-dimensional (3D) tissue formation. The scaffold not only defines the 3D 
geometry of the tissue but also provides the microenvironment for cell attachment, 
proliferation and tissue neo-genesis. 
The scaffolds currently used for cell attachment are typically made up of polymeric 
materials, and the behaviours of the attached cells are modulated by the surface 
properties of the polymeric material (Dalby et al., 2014). Modification of the surface 
properties of the material by presenting chemical and/or physical cues can significantly 
influence the interaction of the cell with the material surface (Ma, 2008, Qiu et al., 2014). 
Plasma treatment is routinely used to prepare the surfaces and facilitate protein 
immobilisation, either by covalent linkage or adsorption, so promoting cell adhesion 
(Nitschke et al., 2002).  
Scaffold surface functionalization is routinely used for developing new tissue 
engineering strategies as it offers the advantage of making material surface cell friendly 
without changing the desirable material properties. The use of extracellular matrix 
(ECM) proteins, in particular, for surface modification could promote cell interaction and 
integration with the material surface (Higuchi et al., 2012). The work of this chapter 
focuses on making surface modifications to mimic the ECM in a facile manner by the 
application of ranaspumin-2 (Rsn2) fusion proteins. 
ECM is mainly composed of glycosaminoglycans and proteins that include collagen, 
elastin, fibronectin and laminin, which have both structural and adhesive functions. Cells 
adhere to their environment with a wide array of membrane spanning cell adhesion 
molecules (CAM) that form the mechano-chemical link to the ECM  (Shekaran and 
Garcia, 2011). Integrins are a prominent member of the CAMs. 
Integrins are one of the principal animal cell membrane receptors used to bind to the 
extracellular matrix. They are heterodimeric in nature, each consisting of an α subunit 
and a β subunit (Hynes, 2002, Barczyk et al., 2010). Integrins function as transmembrane 
linkers between ECM and the actin cytoskeleton. Integrins and conventional signalling 
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receptors often cooperate to promote cell growth, cell survival, and cell proliferation  
(Takada et al., 2007, Hynes, 1999). 
Integrins are known to operate as force dependent mechanotransducers attaching both to 
their ligands within the ECM and the actin cytoskeleton (Hynes, 2002). Activation allows 
bidirectional signalling between the two environs (Schoenwaelder and Burridge, 1999). 
Attachment of integrins to the ECM and aggregation into clusters known as focal 
adhesions sets off a number of intracellular signalling cascades such as the ERK1/2 
mitogen activated protein kinase (MAPK) pathway. The MAPK pathway relies on 
integrin-dependent cell-surface interactions to trigger a chain reaction of kinase 
activation leading to changes in gene transcription and ultimately changes in gene 
expression (Zhu and Assoian, 1995). 
Integrins bind a cell’s surface to the ECM components such as fibronectin, vitronectin, 
collagen, and laminin by binding to specific peptide motifs.. In mammals, eighteen α and 
eight β subunits have been found and have been well characterised.  Through different 
combinations of these α and β subunits, some 24 unique integrins are generated  
(Barczyk et al., 2010). Some integrin α subunits contain an I (interaction) domain and are 
closely related to each other. Also closely related to each other are the family of non-I-
domain α subunits that recognise the RGD motif (Hynes, 2002). Each integrin dimer has 
distinct ligand-binding specificity and the list of various specific integrin-binding short 
peptide sequences that can be used to direct cell adhesion is given in Table 3-1 and Table 
3-2. 
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Integrin 
subunits 
Distribution/ cell type Receptor/Binding Site /Ligand 
α1β1 Dorsal Root Ganglion (DRG), 
fibroblasts, vascular smooth 
muscle, liver, microvascular 
endothelium 
Laminin, collagen 
 
α2β1 Fibroblasts Laminin, collagen, thrombospondin, E-cadherin, tenascin 
α3β1 Fibroblasts, DRG Collagen, Laminin, thrombospondin, fibronectin 
α4β1 Hematopoietic cells Thrombospondin,VCAM-1, fibronectin, osteopontin, 
ICAM-4 
α5β1 DRG, human umbilical vein 
endothelia (HUVEC) 
Fibronectin, osteopontin, fibrillin, thrombospondin,.  
α6β1 DRG (Low expression) Laminin, thrombospondin 
α7β1 Skeletal and smooth muscle 
cells 
Laminin 
α8β1 crypt cell, alveolar interstitial 
cells 
Tenascin, fibronectin, osteopontin, vitronectin, TGF-β, 
nephronectin 
α9β1 T-cells Tenascin, VCAM-1, osteopontin, plasmin, angiostatin, 
VEGF. 
α10β1 Chondrocytes Laminin, collagen 
α11β1 Dermal cells, Periodontal 
ligament cells 
Collagen 
 
αVβ1 Oligodendrocytes, astrocytes, 
pancreatic β cells 
TGF-β, fibronectin, Vitronectin, osteopontin 
αLβ2 T-lymphocytes ICAM, ICAM-4 
αMβ2 Neutrophils and Monocytes ICAM, fibrinogen, ICAM-4, heparin 
αXβ2 Myeloid cells and activated B, 
NK and some cytotoxic T cells 
ICAM, fibrinogen, ICAM-4, heparin, collagen 
αDβ2 Inflamed Macrophages, 
Eosinophils 
ICAM, VCAM-1, fibrinogen, fibronectin, vitronectin, 
plasminogen 
αllbβ3 Platelets Fibrinogen,thrombospondin, fibronectin, vitronectin, 
collagens,  ICAM-4 
 αVβ3 Osteocytes, HUVEC, 
melanoma 
Fibrinogen, vitronectin, thrombospondin, fibrillin, 
tenascin,  fibronectin, osteopontin, Bone Sialoprotein 
(BSP), TGF-β. 
α6β4 DRG, Epithelial cells Fibronectin, Laminin 
αVβ5 Fibroblasts, epithelial cells Osteopontin, BSP, vitronectin,  TGF-β 
αVβ6 Epithelial cells (proliferating) TGF-β, fibronectin, Tenascin, 
Osteopontin 
α4β7 
 
T-cells, Intestinal Mast 
progenitor cells 
MAdCAM-1, VCAM-1, fibronectin, osteopontin 
αEβ7 
 
Tcells (memory) E-cadherin 
αVβ8 Dendritic cells, Langerhans 
cells 
Collagens, Laminins, Fibronectin, TGF-β 
Table 3-1 Integrins and their binding partners. List of different integrin subunits with their protein binding 
ligands found in various types of tissue. Each integrin can bind to more than one protein binding 
ligand.(Anselme, 2000, Plow et al., 2000, Higuchi et al., 2012, Takada et al., 2007, Orla Protein 
technologies, Bennett et al., 2001a, Siebers et al., 2005)  
NOTE: Cells express more than one type of integrin at a time, and expression varies according to the 
stage of cell cycle stage and during development. 
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Integrin binding 
sequence 
 Integrin Reference 
RGD collagen I, vitronectin, 
fibronectin, Bone 
sialoprotein 
α3β1, α5β1, α8β1, 
αvβ1, αvβ3, αvβ5, 
αvβ6, αllbβ3 
(Pytela et al., 1987, Ruoslahti, 
1996b) 
PHSRN Fibronectin α5β1 (Aota et al., 1994) 
IKVAV Laminin α3β1,  α1 chain (Saha et al., 2007, Caniggia et al., 
1996, Nomizu et al., 1995) 
LDVP Laminin α4β1 (Komoriya et al., 1991, Bayless and 
Davis, 2001) 
FHRRIKA BSP, collagen α2β1 (Healy et al., 1999b, Schuler et al., 
2009) 
REDV Fibronectin α4β1 (Humphries et al., 1986, Bayless 
and Davis, 2001) 
KRSR BSP   (Balasundaram and Webster, 2007) 
YIGSR Laminin  β1 chain (Frith et al., 2012) 
(GG)DGEA collagen I α2β1 (Hennessy et al., 2009, McCann et 
al., 1997) 
HHLGGAKQAGDV Fibrinogen γ-chain αllbβ3  (Hagisawa et al., 2016) 
GPR  α2β2  (Graham et al., 2003) 
AEIDGIEL Fibronectin α9β1   (Yokosaki et al., 1998) 
QIDS Fibronectin α4β1 (Clements et al., 1994) 
PPRARI Fibronectin (heparin 
II domain) 
α4β1 (Gonzalez et al., 2009) 
GFOGER Collagen α1β1, α2β1  (Hennessy et al., 2009) 
Table 3-2 Integrin binding sequences (IBS), their molecule(s) of origin, their binding integrins and the 
citation, where the sequences have been described. 
A series of studies where surfaces have been modified such that RGD tripeptide motifs 
are displayed to cells have shown that this can promote cell attachment and proliferation. 
Coating a scaffold material’s surface with only the RGD peptide can limit cell type-
specific adhesion, since all cells express RGD binding integrins. Moreover, binding by 
RGD-directed integrins is only optimal in the presence of other synergistic peptides. For 
instance, the presence of a PHSRN synergy peptide, on fibronectin domain 10, along 
with RGD can substantially enhance the adhesive activity of α5β1 integrin (Redick et al., 
2000).  Some other peptide sequences, like the IKVAV, can mediate α3β1 integrin- 
mediated neurite outgrowth (Tashiro et al., 1989). Thus it is hypothesised that to make a 
surface cell type specific, the availability of a combination of specific integrin binding 
sequence (IBS) might be needed.   
The genetic engineering provides an opportunity to develop recombinant fusion proteins 
containing cell adhesive peptides, which can be used to generate biomimetic biomaterials 
interfaces (Hersel et al., 2003). The biomimetic substrates produced by presenting 
peptide sequences in this manner might then promote cell adhesion. The work described 
in this chapter is building on the cell patterning chapter and is focused on developing a 
functionalised scaffold specialised for osteoblasts, and DRG neurons, using IBS as a 
fusion partner with Rsn2. The selection of IBS was based on the information summarised 
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in Table 3-1 and Table 3-2, which suggests that DRG neurons express α1β1, α3β1 and 
α5β1, while osteoblasts express α3β1 and αVβ3 integrins. Five short biomimetic peptides 
were selected which would bind to these integrins, namely (in standard single letter code) 
RGD, PHSRN, IKVAV, LDVP and FHRIKKA. This was backed by literature that showed 
that use of FHRRIKA and RGD would promote osteoblasts differentiation (Rezania and 
Healy, 1999b), while IKVAV and LDVP would promote neuronal outgrowth (Tashiro et 
al., 1989). Thus we hypothesised that by presenting short peptide sequences, which bind 
to the expressed integrin receptors, like RGD; FHRRIKA and PHSRN on scaffold 
surface would promote osteoblasts adhesion while presenting RGD, PHSRN, IKVAV, and 
LDVP might improve DRG cell adhesion.  
3.2 Aim 
The aim of the work described in this chapter was to develop a tool that allows the 
functionalizing of a wide range of hydrophobic scaffolds with cell type selective IBS-
Rsn2 fusion proteins that have been tailored to promote cell adhesion on otherwise non-
selective surfaces. 
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3.3 Method and Materials 
3.3.1 IBS-Rsn2 cloning and protein expression 
The IBS-Rsn2 expression constructs were created by PCR subcloning. Primers were 
designed, one to anneal to the 5’ end of the Rsn2 non-coding strand that incorporated 
each IBS preceded by a NdeI restriction site; whereas the 3’ end primer would bind to the 
Rsn2 coding strand and contained a BamHI restriction site.  Table 3-3 shows the primer 
sequences. 
Rsn2_FL_3’Primer (3’       5’) : CTA-CTA-CTA-CTA-CTA-CCT-ATA-ATC-CTA-GG 
Rsn2_FL_5’Primer    (5’       3’) 
RGD CAT-ATG-CGT-GGC-GAT-TTA-ATA-TTA-GAT-GGG-GAC-CTA-CTA 
LDVP CAT-ATG-CTG-GAT-GTG-CCG-TTA-ATA-TTA-GAT-GGG-GAC-CTA-CTA 
IKVAV CAT-ATG-ATT-AAA-GTG-GCG-GTG-TTA-ATA-TTA-GAT-GGG-GAC-CTA-CTA 
PHSRN CAT-ATG-CCG-CAT-TCT-CGT-AAC-TTA-ATA-TTA-GAT-GGG-GAC-CTA-CTA 
FHRRIKA CAT-ATG-TTT-CAT-CGT-CGT-ATT-AAA-GCG-TTA-ATA-TTA-GAT-GGG-GAC-CTA-CTA 
Table 3-3 Sequences of primers designed to generate IBS-Rsn2. CAT-ATG is the NdeI site, C-CTA-GG is 
the BamHI site and IBS coding nucleotides are coloured red.  
PCR amplification was then carried out at an annealing temperature of 50⁰C with these 
primers, using the pET28-Rsn2 template to produce an IBS-Rsn2 PCR product. The PCR 
product was subjected to agarose gel electrophoresis, and the excised fragment was then 
subjected to gel purification (Wizard® SV Gel and PCR Clean-Up System) to avoid any 
contaminating template. 3’ adenine overhangs were added to each insert using Taq 
polymerase (GoTaq® Flexi DNA Polymerase # M8301). The fragments were then ligated 
into the pCR4.0-TOPO vector with complementary 3’ thymine overhangs which contain 
immobilised topoisomerase enzyme (Invitrogen). DNA sequencing of the transformed 
DH5 alpha (Invitrogen™) cells were carried out to investigate that the TA-cloned 
fragments had the correct sequence. 
Each IBS-Rsn2 coding sequence was then subcloned. The restriction enzymes NdeI and 
BamHI were used to cut the insert out of the pCR4 vector producing sticky overhangs to 
subclone into the pET-28 expression plasmid (Novagen, #69864) cut with the same 
restriction enzymes. The ligated plasmids were then transformed into E. coli DH5 alpha, 
followed by the selection of clones using colony PCR and DNA sequencing. The 
recombinant plasmid DNA was then ready to be transformed into the expression cells of 
choice, BL21 (DE3) cells (Agilent). 
All the expressed proteins will have his-tag and thrombin cleavage site before the IBS-
Rsn2. The proteins Rsn2, RGD-Rsn2, FHRIKKA-Rsn2 and PHSRN-Rsn2, were 
expressed as described in section 2.2.1. IKVAV-Rsn2 and LDVPRsn2 were expressed 
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overnight at 15°C with all other conditions being the same as outlined in Section 2.2.1 
and given to Dr Kredi for for her to investigate if these would promote axonal outgrowth. 
3.3.2 Contact Angle  
Contact angle measurements for IBS-Rsn2 coated PDMS surfaces were made using the 
protocol described in Chapter 2. 
3.3.3 Silanisation 
The Glass coverslips/slides were cleaned using piranha solution (a 3:1 mixture of 
sulphuric acid and hydrogen peroxide), rinsed with water, and air dried thoroughly. Then 
the glass coverslip/slides were briefly soaked in a minimal volume of silanizing reagent 
(Chlorodimethylsilane, Sigma-Aldrich) and the excess solution was allowed to evaporate 
in the fume hood before thoroughly rinsing with log flumes. Silanised glass 
coverslips/slides were then air dried.  
3.3.4 Routine cell culture 
Cell culture work was performed aseptically at room temperature using laminar flow 
hoods and cells were kept in an incubator at 37°C under humidified conditions with 5% 
CO2. Cells were maintained in modified DMEM culture medium containing foetal 
bovine serum (FBS), antibiotic mixture and sodium pyruvate.  
Fibroblast h-Tert cells were cultured and seeded, as mentioned in chapter two method 
and material section, onto IBS-Rsn2 coated PDMS surfaces for 24 hours. After which 
they were fixed and subjected to DAPI staining for nucleus and immunofluorescence 
microscopy as described later. 
3.3.5 Isolation and culture of osteoblastic cells 
Osteoblastic cells were isolated from neonatal rat calvaria by Dr M Riehle using explant 
culture as briefly described in the following. Firstly, the neonates were schedule 1 killed 
using an overdose of pentorbital and their DRG removed by another user. The same 
animals were collected in sterile plastic bags on ice and 1-4 hours later used to extract the 
calvariae. After cutting through the skin and soft connective tissue the calvariae were 
removed, and collected at room temperature in Hanks' Balanced Salt Solution (GIBCO® 
HBSS). Using a binocular microscope the periosteum and other adhering soft tissue was 
removed from the bone using scalpel blades and Dumont No 7 forceps. The collected, 
soft tissue free calvariae of two rats were then cut into small, ca. 1mm large pieces. The 
bone pieces were washed twice with HBSS  and placed in a 25 cm2 TCP flask with ca. 1-
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2ml DMEM media (10%FBS, 5% ABS, 85% DMEM Sigma) such that the meniscus of 
the media would confine the bone pieces into contact with the substrate. The media 
would be carefully exchanged every three days. After 7-14 days in vitro a cell layer 
would surround the bone pieces. At this stage I would take over the cultures and treat 
these as follows. 
The cell layer was then digested by giving a trypsin-collagenase proteolytic treatment. 
Rat calvaria cells obtained were seeded in a 25 cm2 (T-25) (BD Biosciences, San Jose, 
CA, USA) tissue culture dish. The cells were grown until confluence in Dulbecco's 
Modified Eagle's Medium (DMEM) (PAA Laboratories) supplemented with 10% Foetal 
bovine serum (FBS, Invitrogen), 1% penicillin and streptomycin (Sigma) and sodium 
pyruvate (Sigma).  
Isolated osteoblast cells were seeded into a 75 cm2 (T-75) culture flask (BD Biosciences, 
San Jose, CA, USA) containing medium and incubated. After 48 hrs in culture, the non-
adherent cells were discarded, and cells were fed with fresh medium. The medium was 
replaced twice a week. Cells were allowed to reach 70-80% confluence and then 
passaged as follows: Briefly, the culture medium was aspirated and the cells washed in 
HEPES-saline (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) following which 5 
ml trypsin (PAA Laboratories) was added and incubated at 37°C for 5 minutes. The 
action of trypsin was neutralised by adding 5 ml medium, and a cell count was performed 
using a Neubauer chamber. The cells were then seeded in a 150 cm2 (T-150) culture flask 
(BD Biosciences, San Jose, CA, USA) at a concentration of 100 cells/cm2. 
3.3.6 PDMS fabrication 
PDMS 184 polymer solution  (Sylgard® 184 Silicone Elastomer, Dow Corning, UK) was 
added to curing agent at a ratio of 9:1 (w:w). The polymer and curing agent were mixed 
very thoroughly in a disposable cup and then degassed for 20 minutes. The degassed 
PDMS was poured into a petri dish or a silicon wafer mould and cured in an 80°C oven 
for 2 hours before being left to cool and cut into individual 11 mm diameter devices with 
a 13mm diameter cork borer. 
The unreacted component of the crosslinked PDMS was extracted by three cycles of 
swelling the polymer in n-hexane (Riedel-de Haën), and shrinking of the samples in 
ethanol. 
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3.3.7 Sample preparation 
Samples were sterilised before seeding by immersing them in 70% ethanol for 30 mins, 
after which each sample was rinsed twice in sterilised water followed by drying with a 
flow of 0.22μm filtered compressed air in a laminar flow cabinet. 
For Rsn2, RGD-Rsn2, PHSRN-Rsn2, FHRIKKA-Rsn2, RGD-Rsn2:PHSRN-Rsn2 (1:1), 
RGD-Rsn2:FHRRIKA-Rsn2 (1:1), FHRRIKA-Rsn2:PHSRN-Rsn2 (1:1) and RGD-
Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2 (1:1:1) coatings, protein solution (1 mg/ml total 
concentration) was added to each surface and left to incubate for 30 mins. After this, the 
excess protein solution was removed, and the samples were rinsed in water before 
seeding with cells. 
3.3.8 Differentiation assay   
The osteoblast cells, when about 70% confluent, were used at passage 3 and 4. Cells 
were plated into 12-well tissue culture dishes at a cell seeding density of 1000 cells/cm2. 
Cells were fed thrice in a week. 
For all experiments, coverslips and PDMS used were rinsed in 70% ethanol three times 
followed by further rinsing in sterile PBS saline solution and then cell culture medium. 
Cells were seeded onto ten different surfaces: plain glass coverslips (positive control), 
untreated PDMS (negative controls), Rsn2, RGD-Rsn2, PHSRN-Rsn2, FHRRIKA-Rsn2, 
RGD-Rsn2: PHSRN-Rsn2 (1:1), RGD-Rsn2:FHRRIKA-Rsn2 (1:1), FHRRIKA-
Rsn2:PHSRN-Rsn2 (1:1) and RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2 (1:1:1). 
Samples were fixed after 0, 1, 7 or 28 days in culture. 
3.3.9 Immunofluorescence staining 
After various times after seeding, cultured osteoblast cells were washed three times with 
phosphate buffered saline (PBS) and fixed with 4% formaldehyde/PBS for 15 minutes at 
37°C. Cells were then permeabilized for 5 minutes at 4°C with a permeabilizing solution 
of 0.1% w/v sucrose, 50 mM NaCl, 3 mM MgCl2.6H2O, 20 mM HEPES (4-(2-
hydroxyethyl)-1-piperazine-ethanesulphonic acid) and 0.5% v/v Triton X-100 in 100 ml 
H2O (pH 7.2). Non-specific binding sites were blocked with 1% bovine serum albumin 
(BSA) in PBS for 15 minutes at 37°C. To visualise the actin cytoskeleton a 1% BSA/PBS 
solution of rhodamine-conjugated phalloidin ((1:200), Molecular Probes USA) was used. 
Along with phalloidin, either mouse anti-vinculin(1:150), mouse monoclonal anti-
osteopontin (OPN ) Ig (1:50) or mouse monoclonal anti-osteocalcin (OCN ) Ig (1:50) 
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were made with 1% BSA in PBS . Each stain was added to its respective sample and 
incubated at 37°C. After 1 hr, samples were washed with 0.5% Tween 20 in PBS 3 times 
for 5 minutes to reduce background labelling. After incubation, secondary antibodies 
made in 1% BSA/PBS were added to the respective samples. Horse biotinylated anti-
mouse IgG (1:150) was added to anti- vinculin, anti-OPN and anti-OCN containing 
samples and were further incubated for 1 hr at 37°C. Samples were washed with Tween 
20/PBS as previously described and incubated at 4°C for 30 minutes in a 1% BSA/PBS 
solution of fluorescin isothiocyanate (FITC) conjugated streptavdin ((1:50), Vector 
Laboratories UK). A final washing step was carried out to remove any excess stain. 
Samples were mounted on glass slides using  mountant containing 4’6- diamidino-2-
phenylindole (DAPI, Vector Laboratories UK) and cells were observed using a Zeiss 
Axiophot fluorescence microscope at 20X magnification (0.40 NA). Images were 
captured using an Evolution QEi digital monochromatic CCD camera (Media 
Cybernetics USA) with QCapture imaging software.  
3.3.10 Quantification  
The fluorescence microscopy images were analysed using FIJI software (Schindelin et 
al., 2012) to assess cell density and to quantify the number of focal adhesions per cell. 
The fluorescence images of DAPI stained samples were exported to FIJI, to calculate 
number of particles Figure 3-1. To quantify the number of focal adhesion formed, the 
fluorescence images of vinculing stained samples were exported to FIJI and the threshold 
tool was used to trace the focal cell adhesions formed Figure 3-2. A paired sample T-test 
was used to test statistical significance between the quantitative data obtained from cells 
cultured on different IBS-Rsn2 coated PDMS substrates. The null hypothesis of the 
paired sample T-test assumes that the true mean difference between the paired samples is 
zero and all differences are by random chance. 
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Figure 3-1 A representative fluorescent image of the osteoblast cells cultured on IBS-Rsn2 coated PDMS, 
fixed and stained with DAPI (A), which was used for adjusting threshold (B) for nucleus quantification. 
The red colour indicates the area identified by FIJI after thresholding.  
  
Figure 3-2 A representative fluorescence image of the osteoblast cells cultured on IBS-Rsn2 coated 
PDMS, fixed and stained with vinculin (A), which was used for adjusting threshold (B) for quantification 
of focal adhesions formed. The red colour indicates the area identified by FIJI after thresholding. Scale 
bar is for 100 µm. 
  
B 
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3.4 Results 
3.4.1 IBS-Rsn2 fusion construct cloning 
For tissue engineering applications it is important to develop a functional scaffold 
capable of supporting a functional tissue. For the formation of a functional tissue, the 
adhesion of particular cell types should be directed onto a three-dimensional scaffold. 
This cell type specificity may be achieved by presenting a fusion construct of specific 
integrin binding sequences with Rsn2 on the surface of the scaffold. To test this, five IBS 
sequences were selected and were cloned with Rsn2 to develop recombinant IBS-Rsn2 
proteins.  Specially designed primers for 5’Rsn2 incorporating the IBS coding region 
were used for amplification of each IBS-Rsn2 construct as shown in Figure 3-3.  
The solution structure of Rsn2 determined by NMR revealed that the N-terminal peptide 
of the protein, first 16 residues, was disordered in bulk solution. Previous work by Dr. 
Vance had shown that the presence of the thrombin-cleavable affinity tag in the 
recombinant protein did not affect the protein's surfactant properties (Vance, 2012). 
Indeed, a fusion protein incorporating the small fluorescent domain iLOV (Chapman et 
al., 2008) N-terminal to Rsn2 also retained surface activity (Vance, 2012). Thus it was 
hypothesised that the introduction of an additional peptide sequence at the N-terminus 
would be unlikely to disrupt surface activity. Moreover, the disordered, 16 residue N-
terminal peptide might help in presenting the IBS for cell attachment at a distance from 
the Rsn2-coated surface.  Thus a site immediately preceding the N-terminal leucine 
residue of the natural, mature Rsn2 sequence was chosen for the addition of the IBS 
peptide.   
The PCR products obtained were gel purified and used for TOPO TA cloning into the 
pCR4.0 vector. Competent cells were then transformed with the vector carrying IBS 
Rsn2 gene generating many colonies. 
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Figure 3-3 PCR amplification of IBS-Rsn2 product using primers incorporating IBS, where (1) no 
template negative control; (2) RGD-Rsn2; (3) LDVP-Rsn2; (4) PHSRN-Rsn2; (5) IKVAV-Rsn2; (6) 
FHRRIKA-Rsn2, (7) Rsn2 as a positive control; (M) 100bp ladder. The red arrow points to the amplified 
IBS-Rsn2 fragments of almost 300bp. 
 
Figure 3-4 Colony PCR. Screening of colonies for the correct insert using PCR for all five IBS-Rsn2 
fusion construct (1-5) colonies selected for colony PCR and (M) 100bp ladder. The orange arrows 
indicate the amplified IBS-Rsn2 fragments of almost 500bp.  
Colony PCR was performed using M13 primers to screen for the presence of the insert in 
the pCR4.0 vector. The expected sizes of the colony PCR products are for RGD: 474bp, 
LDVP is 477bp, PHSRN is 480bp, IKVAV is 480bp, FHRRIKA is 486bp and positive 
control is 165bp. Agarose gel electrophoresis Figure 3-4 revealed that all selected 
colonies gave rise to a PCR product of the expected size insert except PHSRN 1. Plasmid 
DNA was extracted from each positive clones and sequenced (University of Dundee). 
The sequencing results confirmed that the positive clones carried the right sequences. 
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Figure 3-5 A 1% agarose gel for double digested vector and insert with NdeI and BamHI, where M is 100 
bp Ladder, 1 is Rsn2 uncut, 2 is BamHI control, 3 is NdeI control, 4;5;6;7;8;9;10 are double digests for 
Rsn2; RGD; LDVP; PHSRN; IKVAV; FHRRIKA; pET28 vector (followed by Alkaline  Phosphatase 
treatment) The red arrow points to the IBS-Rsn2 fragments generated after double digestion.  
Once confirmed, each pCR4.0 vector carrying an insert was subjected to double digestion 
with NdeI and BamHI to produce the desired insert flanked with the respective restriction 
sites. In parallel, the destination vector, pET28, was double digested and subjected to 
alkaline phosphatase treatment to prevent self-ligation. The double digest was subjected 
to agarose gel electrophoresis Figure 3-5, and each band of the correct size was excised 
and gel extracted followed by overnight ligation into the pET28 vector. 
 
Figure 3-6 An example of agarose gel electrophoresis of colony PCR products from selected IBS-Rsn2 
constructs ligated into pET28 and transformed into DH5alpha cells, where M is 100bp ladder, 1-5 are 
RGD colonies, 6 and 7 PHSRN, 8 IKVAV, 9 no plasmid negative control and 10 Rsn2 as a positive 
control. Colonies labelled in red are positive clones. The red arrow points to the amplified IBS-Rsn2 
products.  
The ligated construct was then transformed into competent cells and the clones obtained 
were screened by colony PCR Figure 3-6, positive clones were sequenced (Figure 3-7). 
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The sequencing result allowed the identification of plasmids that had the correct 
sequence for each IBS-Rsn2.  
 
Figure 3-7 An example of the sequencing result for IBS-Rsn2 in pET28 vector confirmed the insertion of 
RGD (IBS) between the start codon and Rsn2 gene. 
3.4.2 IBS-Rsn2 fusion protein expression 
Following successful construction of each expression vector, each IBS-Rsn2 vector was 
transformed into BL21 (DE3) cells and expression of the individual proteins tested.  
SDS-PAGE analysis of RGD-Rsn2; LDVP-Rsn2; PHSRN-Rsn2 and FHRRIKA-Rsn2 
revealed their presence in both soluble and insoluble fractions whereas the majority of 
the IKVAV-Rsn2 was in the insoluble fraction. 
Since significant proportions of each IBS-Rsn2, Rsn2 was found in the insoluble fraction 
in the small scale test expressions, large-scale expression tests were set up to investigate 
whether sufficient IBS-Rsn2 could be expressed and purified successfully.  Following 
purification of each IBS-Rsn2, they were subjected to SDS-PAGE to check the purity and 
integrity of each protein. The yield of purified protein obtained for RGD-Rsn2 and 
PHSRN-Rsn2 was more than 10 milligrames per litre of culture (mg/L) (Figure 3-8), and 
for FHRRIKA-Rsn2 it was nearly 8 mg/L, whereas LDVP-Rsn2 gave 4 mg/L and 
IKVAV-Rsn2 2.5 mg/L. Since LDVP-Rsn2 and IKVAV-Rsn2 gave low yields of soluble 
protein (Figure 3-9), steps were taken to optimise their expression conditions.  
Optimisations were carried out by reducing the incubation temperature and extending the 
time of induction from 37⁰C for 3 hours to 15⁰C overnight, and by reducing the IPTG 
concentration from 1mM to 0.4mM or 0.1mM. Test expressions carried out using these 
conditions showed that reducing the temperature to 15⁰C with 1 mM IPTG induction 
resulted in most of the protein being found in the soluble fraction. The results of the test 
expression were assessed on a larger scale culture which gave yields above 10 mg/L for 
both LDVP-Rsn2 and IKVAV-Rsn2 (Figure 3-10). 
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Figure 3-8 SDS-PAGE of PHSRN-Rsn2 affinity purification, where (1) Cell lysate flow through; (2) 
Binding buffer1; (3) Binding buffer2; (4)Wash buffer1; (5) Elution buffer1; (6) Elution buffer2; (7) 1M 
immidazole and (M) Marker. The red arrow points to the right sized expressed protein almost 14 kDa.  
 
Figure 3-9 SDS-PAGE of the five IBS-Rsn2 samples after Ni
2+
-affinity purification, where (1) RGD-Rsn2; 
(2) LDVP-Rsn2; (3) PHSRN-Rsn2; (4) IKVAV-Rsn2; (5)FHRRIKA-Rsn2 and (M) Marker. The red arrow 
points to the expected size for the expressed proteins of almost 14 kDa.  
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Figure 3-10 SDS-PAGE of IKVAV-Rsn2 affinity purification.(1) Cell lysate flow through; (2) Binding 
buffer1; (3) Wash buffer1; (4) Elution buffer1; (5) Elution buffer2; (6) 1M immidazole and (M) Marker. 
The red arrow points to the right sized expressed protein of almost 14 kDa.  
3.4.3 Contact angle measurements 
Following successful expression and purification of each of the IBS-Rsn2, their effects 
on the surface modification of PDMS was assessed using contact angle measurements to 
confirm that their surface activity is not hindered by the addition of short peptide the N-
terminus of the protein. For this, each IBS-Rsn2 was used to coat PDMS and the water 
contact angle of these coated surfaces measured. Rsn2, uncoated PDMS and silanized 
glass were used as positive and negative controls. The results obtained showed that all 
the IBS-Rsn2 proteins could reduce the surface tension by coating a hydrophobic surface.  
The contact angle measurement is there to show that the IBS-Rsn2s all stick to the 
surface, but approximately equal loading is only assumed, but not measured. The results 
of the contact angle measurements suggests that the angle of contact could be changed by 
the different natures of the IBSs themselves. 
 For future work, it would be better to quantitatively measure the coverage of different 
Rsn2 mutants at the surface. For achieving this, specially designed antibodies should be 
used against specific IBS-Rsn2 coated surface, to prove the presence of IBS-Rsn2 on 
surface. Upon confirmation of the presence of IBS-Rsn2, it would be seeded with cells 
and if  the cells  adhesion is restricted on the conjugated antibody-IBS-Rsn2 surface 
compared to IBS-Rsn2 surface, then it would suggests that IBS-Rsn2 is available  for cell 
attachment.  
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Figure 3-11 Graphical representation of the contact angle measurement of the droplet of water on various 
IBS-Rsn2 coated PDMS surface. The average water contact angle was used along with ±SD on different 
IBS-Rsn2 coated PDMS surfaces. Measurements were made immediately after coating a PDMS surface 
with the proteins. (n=3 repeats). 
3.4.4 Fibroblast cell culture on different IBS-Rsn2 coated PDMS 
Once it was confirmed that the IBS-Rsn2 proteins coat PDMS substrates, as judged by 
the reductions in surface tension seen, the next step was to check whether the IBS were 
available to bind to cells or were concealed in the protein surface structure. To 
investigate this, IBS-Rsn2 coated PDMS samples were seeded with fibroblast (hTert) 
cells, cultured for 24 hours and the cell density calculated. A striking difference in cell 
density was seen between uncoated PDMS and Rsn2-coated samples, as seen earlier in 
cell patterning chapter. The cell densities on each of the IBS-Rsn2 were also higher than 
on the uncoated coated PDMS and even exceeded the densities seen with Rsn2 (Figure 
3-12) Thus, since the cell densities seen were higher for all the IBS-Rsn2 coated samples 
than for Rsn2 alone, it seems likely that the IBS are available for cell binding and exert a 
positive effect. 
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Figure 3-12 Cell density of fibroblast cells cultured on various IBS-Rsn2. Fibroblast cells were cultured 
on protein coated PDMS surface for 24 hours and cell density calculated following immunofluorescence 
microscopy for nucleus staining. (A) A representative image of nucleus staining on un-coated PDMS 
surface. (B) A representative image of nucleus staining on RGD-Rsn2 coated PDMS surface. (C) A 
graphical representation of cell density obtained in different IBS-Rsn2. RGD-Rsn2 is significantly 
different from all the other samples. Stars indicate significant differences between the different coatings as 
determined by paired sample T-test, Where ***p<0.001. The bars indicate standard deviation (n=3 
repeats) 
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3.4.5 Osteoblast cell culture on IBS-Rsn2 coated PDMS 
Having established that all the IBS-Rsn2 proteins could promote fibroblast cell adhesion 
on PDMS, coated PDMS substrates were cultured with primary calvaria bone cells.  
As the IBS-Rsn2 were designed to support nerve and osteoblast cells, IBS-Rsn2 proteins 
expected to promote nerve cell outgrowth by binding neuron specific integrin (α1β1, α3β1 
and α5β1) were passed to a co-worker, Dr Kredi, who showed that IKVAV-Rsn2 
improved nerve outgrowth from rat dorsal root ganglion explants (Kredi, 2015). For the 
osteoblast cell culture work, IBS-Rsn2 incorporating either RGD, or the PHSRN and 
FHRRIKA sequences that are ligands for the osteoblast specific integrins (α3β1 and αVβ3) 
were used to investigate their effects on osteoblast adhesion and differentiation. 
3.4.5.1 Osteoblasts after 4 hrs in culture 
After 4 hrs (day 0) in culture, cells seeded on RGD-Rsn2, RGD-Rsn2:PHSRN-Rsn2 
(1:1), and RGD-Rsn2:PHSRN-Rsn2: FHRRIKA-Rsn2 (1:1:1) had adhered to the surface 
and displayed extended morphologies compared to the control coatings (glass and Rsn2). 
In contrast, Rsn2, PHSRN-Rsn2, FHRIKKA-Rsn2, RGD-Rsn2:FHRRIKA-Rsn2 (1:1) 
and PHSRN-Rsn2:FHRRIKA-Rsn2 (1:1) did not promote osteoblasts spreading at this 
time point (Figure 3-13). 
This qualitative analysis is supported by comparing the cell densities and the average 
number of focal adhesions per cell (Figure 3-14 and Figure 3-15). The number of focal 
adhesions seen per cell was assessed to establish which of the surfaces tested provided 
the best environment to support cell attachment. The highest number of focal cell 
adhesions per cell formed on RGD-Rsn2 and RGD-Rsn2: PHSRN-Rsn2: FHRRIKA-
Rsn2 (1:1:1) coated surfaces. This was followed by the RGD-Rsn2:PHSRN-Rsn2 (1:1) 
and the other coatings did not support the formation of focal adhesions by osteoblasts. 
The results can only enlighten about the osteoblast’s preferences for the formation of the 
initial cell attachments. The next step was to see which coating provided the best surface 
for osteoblast development after longer time in culture. 
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Figure 3-13 Immunofluorescence images of osteocytes after 4 hours in culture 
on IBS-Rsn2 coated PDMS. After 4 hours (day 0) in culture, osteocytes showed 
extended morphology on RGD-Rsn2 coated surfaces, while some spreading was 
also observed on RGD-Rsn2: PHSRN-Rsn2 and RGD-Rsn2: PHSRN-Rsn2: 
FHRRIKA-Rsn2 coated surfaces. The actin filaments are represented in red, 
vinculin in green and nuclei in blue. Scale bar is 100 µm.  (Where  A=Glass, 
B=PDMS, C=Rsn2, D=RGD-Rsn2, E=PHSRN-Rsn2, F=FHRRIKA-Rsn2, 
G=RGD-Rsn2:PHSRN-Rsn2, H=RGD-Rsn2:FHRIKA-Rsn2, I=PHSRN-
Rsn2:FHRIKA-Rsn2, J= RGD-Rsn2:PHSRN-Rsn2:FHRIKA-Rsn2) 
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Figure 3-14 Density of cells on various IBS-Rsn2 coated surface after 4 hours in culture. The graph 
represents the average number of  osteoblasts cells/cm
2 
 after 4 hours in culture on Glass and Rsn2 - 
positive control, PDMS - negative control, and test - RGD-Rsn2 (R) coated PDMS, PHSRN-Rsn2 (P) 
coated PDMS, FHRRIKA-Rsn2 (F) coated PDMS, R:P (RGD-Rsn2:PHSRN-Rsn2) coated PDMS, R:F 
(RGD-Rsn2:FHRRIKA-Rsn2) coated PDMS, P:F (PHSRN-Rsn2: FHRRIKA-Rsn2) coated PDMS and 
R:P:F (RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2) coated PDMS. RGD-Rsn2 and R:P:F-Rsn2 are 
significantly different from all the other samples. Stars indicate significant differences between the 
different coatings as determined by paired sample T-test, Where ***p<0.001. The bars indicate standard 
deviation (n=3 biological repeats). 
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Figure 3-15 Graphical representation of the quantified number of focal adhesion formed per cells on 
various IBS-Rsn2 coated surfaces after 4 hours in culture. The graph represents the number of FCA per 
cells after 4 hours in culture on Glass and Rsn2 - positive control, PDMS - negative control, and test - 
RGD-Rsn2 (R) coated PDMS, PHSRN-Rsn2 (P) coated PDMS, FHRRIKA-Rsn2 (F) coated PDMS, R:P 
(RGD-Rsn2:PHSRN-Rsn2) coated PDMS, R:F (RGD-Rsn2:FHRRIKA-Rsn2) coated PDMS, P:F (PHSRN-
Rsn2: FHRRIKA-Rsn2) coated PDMS and R:P:F (RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2) coated 
PDMS. RGD-Rsn2 and R:P:F-Rsn2 are significantly different from all the other samples. Stars indicate 
significant differences between the different coatings as determined by paired sample T-test, Where 
***p<0.001. The bars indicate standard deviation (n=3 biological repeats). 
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3.4.5.2 Osteoblasts after 1 and 7 days in culture 
All osteoblast cells were cultured on different IBS-Rsn2 coated PDMS for either one or 
seven days and compared with bare glass, PDMS and Rsn2-coated PDMS controls. The 
cell density, formation of focal adhesions, and morphology of the osteoblasts varied 
considerably on the different coatings.  
At the 1 day time point, the highest cell density, most extended morphology, and highest 
number of focal adhesions per cell were observed on RGD-Rsn2 and RGD-
Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2 (1:1:1) coated surfaces.  Higher cell density with 
some cell spreading and formation of focal cell adhesions was also observed on RGD-
Rsn2:PHSRN-Rsn2 (1:1) and RGD-Rsn2:FHRRIKA-Rsn2 (1:1), compared to the glass 
and Rsn2 controls. In contrast, lower cell density; focal cell adhesions and cell spreading 
were observed on PHSRN-Rsn2, FHRIKKA-Rsn2, and PHSRN-Rsn2: FHRRIKA-Rsn2 
(1:1) coated surfaces (Figure 3-16 to Figure 3-18).   
After 7 days in culture, the highest cell densities were observed in RGD-Rsn2 and RGD-
Rsn2: PHSRN-Rsn2: FHRRIKA-Rsn2 (1:1:1), followed by RGD-Rsn2: FHRRIKA-Rsn2 
(1:1). Quantification of focal cell adhesions were not made as two samples had such a 
high cell density that cells had become confluent on the surface and even overgrown each 
other. Vinculin staining revealed the formation of focal cell adhesions on RGD-Rsn2: 
PHSRN-Rsn2 (1:1); RGD-Rsn2: FHRRIKA-Rsn2 (1:1); PHSRN-Rsn2: FHRRIKA-Rsn2 
(1:1) as well as FHRRIKA-Rsn2 coated samples (Figure 3-19 and Figure 3-20). 
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Figure 3-16 Immunofluorescence images of osteocytes after 1 day in culture on 
IBS-Rsn2 coated PDMS. Cells showed extended morphology on all but PDMS 
sample. Cell density was found to be highest in RGD-Rsn2 and RGD-Rsn2: 
PHSRN-Rsn2: FHRRIKA-Rsn2 coated surfaces. The actin filaments are 
represented in red, vinculin in green and nuclei in blue. Scale bar is 100 µm. 
(Where  A=Glass, B=PDMS, C=Rsn2, D=RGD-Rsn2, E=PHSRN-Rsn2, 
F=FHRRIKA-Rsn2, G=RGD-Rsn2:PHSRN-Rsn2, H=RGD-Rsn2:FHRIKA-
Rsn2, I=PHSRN-Rsn2:FHRIKA-Rsn2, J= RGD-Rsn2:PHSRN-Rsn2:FHRIKA-
Rsn2) 
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Figure 3-17 Density of cells on various IBS-Rsn2 coated surface after 1 day in culture. The graph 
represents the average number of  osteoblasts cells/cm
2 
 after 1days in culture on Glass and Rsn2 - 
positive control, PDMS - negative control, and test - RGD-Rsn2 (R) coated PDMS, PHSRN-Rsn2 (P) 
coated PDMS, FHRRIKA-Rsn2 (F) coated PDMS, R:P (RGD-Rsn2:PHSRN-Rsn2) coated PDMS, R:F 
(RGD-Rsn2:FHRRIKA-Rsn2) coated PDMS, P:F (PHSRN-Rsn2: FHRRIKA-Rsn2) coated PDMS and 
R:P:F (RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2) coated PDMS. RGD-Rsn2 and R:P:F-Rsn2 are 
significantly different from all the other samples. Stars indicate significant differences between the 
different coatings as determined by paired sample T-test, Where ***p<0.001. The bars indicate standard 
deviation (n=3 biological repeats). 
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Figure 3-18 Graphical representation of the quantified number of FCA per cells on various IBS-Rsn2 
coated surfaces after 1 day in culture. The graph represents the number of FCA per cells after 1 day in 
culture on Glass and Rsn2 - positive control, PDMS - negative control, and test - RGD-Rsn2 (R) coated 
PDMS, PHSRN-Rsn2 (P) coated PDMS, FHRRIKA-Rsn2 (F) coated PDMS, R:P (RGD-Rsn2:PHSRN-
Rsn2) coated PDMS, R:F (RGD-Rsn2:FHRRIKA-Rsn2) coated PDMS, P:F (PHSRN-Rsn2: FHRRIKA-
Rsn2) coated PDMS and R:P:F (RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2) coated PDMS RGD-Rsn2 and 
R:P:F-Rsn2 are significantly different from all the other samples. Stars indicate significant differences 
between the different coatings as determined by paired sample T-test, Where ***p<0.001. The bars 
indicate standard deviation (n=3 biological repeats). 
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Figure 3-19. Immunofluorescence images after 7 days in culture. Cells showed 
extended morphology in all samples except PDMS. Cell density was found to be 
highest in RGD-Rsn2 and RGD-Rsn2: PHSRN-Rsn2: FHRRIKA-Rsn2 coated 
surfaces. Colours are actin (red), vinculin (green), nuclei (blue); scale bar is 
100 μm. (Where  A=Glass, B=PDMS, C=Rsn2, D=RGD-Rsn2, E=PHSRN-
Rsn2, F=FHRRIKA-Rsn2, G=RGD-Rsn2:PHSRN-Rsn2, H=RGD-
Rsn2:FHRIKA-Rsn2, I=PHSRN-Rsn2:FHRIKA-Rsn2, J= RGD-Rsn2:PHSRN-
Rsn2:FHRIKA-Rsn2) 
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Figure 3-20 Density of cells on various IBS-Rsn2 coated surface after 7 days in culture. The graph 
represents the average number of  osteoblasts cells/cm
2 
 after 7days in culture on Glass and Rsn2 - 
positive controls, PDMS - negative control, and test - RGD-Rsn2 (R) coated PDMS, PHSRN-Rsn2 (P) 
coated PDMS, FHRRIKA-Rsn2 (F) coated PDMS, R:P (RGD-Rsn2:PHSRN-Rsn2) coated PDMS, R:F 
(RGD-Rsn2:FHRRIKA-Rsn2) coated PDMS, P:F (PHSRN-Rsn2: FHRRIKA-Rsn2) coated PDMS and 
R:P:F (RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2) coated PDMS. RGD-Rsn2 and R:P:F-Rsn2 are 
significantly different from all the other samples. Stars indicate significant differences between the 
different coatings as determined by paired sample T-test, Where ***p<0.001. The bars indicate standard 
deviation (n=3 biological repeats) 
3.4.6 Comparison of the cell density of osteoblasts at various time points 
The cell densities of the osteoblasts on different IBS-Rsn2 coated PDMS were compared 
at the different time points assessed and the data are shown in Figure 3-21. When 
compared to bare PDMS, PDMS coated with Rsn2 alone and with all the IBS-Rsn2 
proteins tested promoted cell adhesion at all the time points. The initial densities of 
attached cells (after 4 hours in culture) were substantially higher on RGD-Rsn2 coated 
surfaces than for most of the other IBS, except for the mixed RGD-Rsn2:PHSRN-
Rsn2:FHRRIKA-Rsn2 (1:1:1) surface. This early time point was used to establish which 
IBS is best situated for osteocyte adhesion. The more prolonged cultures, after 1 day and 
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7 days, also showed the same trend in cell density, suggesting osteoblasts preference to 
form attachment on the RGD-Rsn2 and RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2 
(1:1:1) coated surface compared to other IBS-Rsn2.  
The RGD-Rsn2 and RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2 coated surfaces were not 
only preferred by osteoblasts for cell adhesion, but also promoted growth and cell 
division compared to other IBS-Rsn2 coated surfaces as can be seen by comparing the 
cell densities in Figure 3-17 and Figure 3-20. In contrast, on the PHSRN-Rsn2, 
FHRRIKA-Rsn2 and PHSRN-Rsn2:FHRRIKA-Rsn2 coated surfaces the cell density did 
not increase. 
 
 
Figure 3-21 Density of cells on day0, day1 and day7. The graph represents the average number of 
osteoblasts cells/cm
2 
 after 0, 1 and 7days of culture on Glass and Rsn2combining the data from figures 
23, 25 and 27. In sequence the data is plotted for positive controls, PDMS - negative control, and test - 
RGD-Rsn2 (R) coated PDMS, PHSRN-Rsn2 (P) coated PDMS, FHRRIKA-Rsn2 (F) coated PDMS, R:P 
(RGD-Rsn2:PHSRN-Rsn2) coated PDMS, R:F (RGD-Rsn2:FHRRIKA-Rsn2) coated PDMS, P:F (PHSRN-
Rsn2: FHRRIKA-Rsn2) coated PDMS and R:P:F (RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2) coated 
PDMS. The bars indicate standard deviation. 
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Figure 3-22.Quantification of the average number of focal cell adhesions per cell on day0 and day1. The 
graph represents the average number of  focal cell adhesions per cell  after 0 and 1 days of culture on 
Glass and Rsn2- positive controls, PDMS - negative control, and test - RGD-Rsn2 (R) coated PDMS, 
PHSRN-Rsn2 (P) coated PDMS, FHRRIKA-Rsn2 (F) coated PDMS, R:P (RGD-Rsn2:PHSRN-Rsn2) 
coated PDMS, R:F (RGD-Rsn2:FHRRIKA-Rsn2) coated PDMS, P:F (PHSRN-Rsn2: FHRRIKA-Rsn2) 
coated PDMS and R:P:F (RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-Rsn2) coated PDMS. The bars indicate 
standard deviation. 
3.4.7 Osteopontin and Osteocalcin expression  
All the protein coated samples were cultured for 28 days and were immunolabelled to 
visulise the expression of the bone cell marker proteins OPN and OCN. Although cells 
grown on all the IBS-Rsn2 coated samples showed expression of OPN, RGD-
Rsn2:PHSRN-Rsn2: FHRRIKA-Rsn2 (1:1:1) coated sample showed the most prominent 
expression over all the other coatings (Figure 3-23). 
Similarly, the determination of expression of OCN in all samples showed varying levels 
of expression across all the samples. OCN expressions level was also most prominent in 
RGD-Rsn2: PHSRN-Rsn2: FHRRIKA-Rsn2 coated samples compared to all the other 
coatings. The immunofluorescence images of all the samples stained for OCN are shown 
in Figure 3-24.  
90 
 
    
    
  
Figure 3-23 Immunofluorescence images for osteopontin after 28 days. The 
presence of osteopontin was observed on glass – positive control and all of the 
protein-coated surfaces, except PDMS. RGD-Rsn2: PHSRN-Rsn2: FHRRIKA-
Rsn2 showed the highest expression of osteopontin compared to all other 
samples. The actin filaments are represented in red, osteopontin in green and 
nuclei in blue. Scale bar is 100 µm. (Where  A=Glass, B=PDMS, C=Rsn2, 
D=RGD-Rsn2, E=PHSRN-Rsn2, F=FHRRIKA-Rsn2, G=RGD-Rsn2:PHSRN-
Rsn2, H=RGD-Rsn2:FHRIKA-Rsn2, I=PHSRN-Rsn2:FHRIKA-Rsn2, J= RGD-
Rsn2:PHSRN-Rsn2:FHRIKA-Rsn2) 
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Figure 3-24 Immunofluorescence images for osteocalcin after 28 days. The 
presence of osteocalcin was observed on glass – positive control and all of the 
protein-coated surfaces, except PDMS. RGD-Rsn2: PHSRN-Rsn2: FHRRIKA-
Rsn2 showed higher expression of osteocalcin compared to all the other 
samples. The actin filaments are represented in red, osteocalcin in green and 
nuclei in blue. Scale bar is 100 µm. (Where  A=Glass, B=PDMS, C=Rsn2, 
D=RGD-Rsn2, E=PHSRN-Rsn2, F=FHRRIKA-Rsn2, G=RGD-Rsn2:PHSRN-
Rsn2, H=RGD-Rsn2:FHRIKA-Rsn2, I=PHSRN-Rsn2:FHRIKA-Rsn2, J= RGD-
Rsn2:PHSRN-Rsn2:FHRIKA-Rsn2). 
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3.5 Discussion 
Biomaterials have a vital role in tissue engineering as they provide a surface where cells 
can attach, develop and proliferate. Surface modifications are routinely made to augment 
the biocompatibility of scaffolds (Chan and Leong, 2008b). For this, usually various 
bioactive molecules or growth factors are introduced to control and enhance cell 
interactions, proliferation, differentiation and generation of ECM (Chan and Leong, 
2008b).  
Bioactive molecules can be presented on the surface by adsorption or via covalent 
modifications, made after plasma treatment. The bioactive molecules used can either be 
whole ECM protein or short cell adhesive peptide sequences. Moreover, during the 
modification process, short peptides tend to be more stable and can be easily mass-
produced in laboratories (Tallawi et al., 2015). Thus short biomimetic peptides were 
selected for making fusion constructs with Rsn2 using recombinant protein technology.  
Rsn2 through its surface activity adsorbs to scaffold surfaces (as shown and discussed in 
chapter 2) allowing the establishment of a simple and easy to replicate method to bio-
functionalize a surface with accessible active sites. IBS-Rsn2 constructs were designed, 
successfully expressed, and the proteins isolated and purified. These IBS-Rsn2 proteins 
all proved to be surface active as judged by contact angle measurements and the addition 
of short peptides to the N-terminus of Rsn2 did not significantly affect its functionality.    
Having confirmed that all of the IBS-Rsn2 were surface active, they were used to coat 
PDMS substrates and seeded with h-Tert cells, and then cultured for 24 hours discover 
whether the IBS presented on Rsn2 were available for cell attachment. The literature 
reveal that not all the proteins containing RGD sequence can mediate cell attachment, 
and only a few of them can do so (Ruoslahti, 1996a). This is because the RGD sequence 
might not be presented on the surface of protein and so be available for integrin binding 
(Pierschbacher and Ruoslahti, 1987). The h-Tert cell results confirmed that all the IBS 
presented on Rsn2 were available for attachment as the cell density on all of the IBS-
Rsn2 coated substrates came out to be higher than the cell densities observed on Rsn2 
alone coated surfaces (Figure 3-21) suggesting that the N-terminus of Rsn2 remains 
flexible and tolerates the addition of short peptides (Vance, 2012, Mackenzie et al., 
2009). Thus the designed constructs were functional and were then used to study which 
IBS promoted osteoblast adhesion, proliferation and differentiation in a manner similar 
to Dalby et al (Dalby et al., 2007).  
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Interactions between osteoblasts and the ECM of bone that are mediated by integrin 
receptors are important determinants of the cells proliferation, differentiation and 
expression of osteocalcin (OCN) and osteopontin (OPN) (Bennett et al., 2001b)  
To test the ability of different IBS-Rsn2 coated surfaces to influence the differentiation of 
cells cultured on them, primary bone cells were used since they are both more 
differentiable than fibroblasts and express a different subset of integrins. Out of several 
IBS-Rsn2 tested, RGD-Rsn2 and the mixture of RGD-Rsn2:PHSRN-Rsn2:FHRRIKA-
Rsn2 (1:1:1) outperformed others in initial cell adhesion, cell spreading and proliferation.  
The work presented in this chapter agrees with other studies using RGD, the fibronectin-
derived IBS, favoured cell attachment from day 0 and also showed enhanced cell 
spreading and proliferation, along with OPN and OCN expression after day 28. These 
observations are in line with observations made by Fraioli et al., who used 
peptidomimetic ligands to functionalise surfaces to promote αvβ3 or α5β1 integrin 
mediated osteoblast adhesion. They observed enhanced cell attachment and spreading 
along with cell proliferation and higher mineralization on the surfaces coated with the 
ligands (Fraioli et al., 2015). Similarly, Wang et al observed that α5β1 integrin is the 
dominant integrin that initiates the osteoblasts attachment with the RGD-cell binding site 
on fibronectin.  (Wang et al., 2010). A similar observation has been made by Dr. Roberts 
in our lab, who showed that upon interaction of mesenchymal stem cells with RGD-
immobilised surface, favoured bone cell differentiation, and enhanced OPN and OCN 
expression (Roberts, 2013).  
The obtained results of RGD as a cell adhesive peptide are in agreement with some other 
studies, where chemically attached RGD has been shown to favour initial cell 
attachment, spreading and mineralisation of osteoblast cells (Beuvelot et al., 2009, Bell 
et al., 2011, Hu et al., 2003). 
All this observation made earlier and in this thesis proves that functionalising surface 
with RGD will promote bone cell attachment and mineralisation.  
The results obtained in this thesis also suggest that mimicking ECM by presenting more 
than one type of IBS (e.g. sample 10 R:P:F) resulted in enhanced focal adhesion 
formation, along with expression of OCN and OPN. These results are in agreement with 
the results of cell binding assays conducted by Gronthos et al. who showed that 
osteoblasts have the ability to adhere to different ECM proteins with a preference to 
fibronectin over collagen, vitronectin and laminin (Gronthos et al., 1997). The findings 
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presented by Healy et al.  also showed that by presenting more than one type of IBS 
together promoted cell spreading and mineralization, mediated by the collagen and 
vitronectin receptors (Healy et al., 1999a) 
Many studies have been conducted using RGD in combination with other peptides, to 
mimic the ECM, and have found to have positively affected osteoblasts’ development 
and mineralisation. One such study used cell-binding peptide RGD along with the 
synergistic peptide PHSRN, found in fibronectin, and saw enhanced differentiation of,  
and calcium deposition by the cultured osteoblasts (Nakaoka et al., 2013, García et al., 
2002, Petrie et al., 2006). 
Another study showed that rat calvaria cells cultured on immobilised biomimetic peptide 
surfaces had a preference for RGD:FHRRIKA. In that study RGD alone showed the 
highest number of focal adhesions per cell formed after 4 hours in culture, while 
RGD:FHRRIKA surface showed mineralisation of the matrix after 24 days in culture 
(Rezania and Healy, 1999a). A similar study used bio-mimetic peptide sequence RGD in 
combination with KRSR or FHRRIKA, heparin-binding peptide sequences, for 
promoting osteoblast outgrowths. They found out that when RGD is used along with 
other peptides, osteoblast migration and outgrowth was stimulated (Schuler et al., 2009). 
Both these studies suggest that RGD if used in combination with PHSRN and /or 
FHRRIKA, to mimic ECM, will enhance osteoblastic development (Mrksich, 2009). 
To summarise, all of the IBS-Rsn2 coated PDMS were biocompatible for 28 days in 
culture, suggesting that the protein coating is stable for that long, or that cells once 
attached and differentiation initiated, the ECM they deposit interacts sufficiently well 
with the substrate to keep them attached. Also, that IBS-Rsn2 can be successfully used to 
mimic ECM, which in this case up to three fusion constructs were used. Result 
successfully show that osteoblast cells preferred RGD-Rsn2 and RGD-Rsn2: PHSRN-
Rsn2: FHRRIKA-Rsn2 (1:1:1) over the other Rsn2 constructs; and that these coatings 
promoted initial cell attachment, osteoblast differentiation and matrix mineralisation.  
RGD-Rsn2: PHSRN-Rsn2 (1:1) and RGD-Rsn2: FHRRIKA-Rsn2 (1:1) also positively 
influenced osteoblast differentiation as compared to the controls.  
To conclude, RGD-Rsn2 alone, or in combination with PHSRN-Rsn2 and/or FHRRIKA-
Rsn2, favour the adhesion and spreading of osteoblast cells to PDMS surfaces that have 
been simply coated with them and support differentiation of the cells as judged by the 
expression of protein markers of mature osteoblasts.  
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4 Stabilisation of micro-emulsions droplets 
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4.1 Introduction 
This chapter describes work undertaken in an effort to demonstrate the use of EP protein 
to direct biomineralisation onto surfaces that do not naturally support this process. 
Specifically, the aim was to make mineralised droplets stabilised by surfactant Rsn2 
protein and mineralising it with biomineralising EP protein. The rationale was that Rsn2 
being a surfactant protein will act on air-water interface and will stabilise the droplets, 
while the EP protein being a biomineralising protein will mineralise the droplets when 
subjected to calcium containing solution. The obtained the mineralised droplets could be 
used for drug delivery, cosmetics, fabricating microcapsules, and other applications. 
4.1.1 Biomineralisation 
Living organisms deposit minerals to form skeletal architecture to perform a range of 
functions including support, mobility and protection (Veis, 2010). Minerals comprising 
carbonate, silica and phosphates are combined with proteins, carbohydrates and lipids, 
generating a staggering range of skeletal architecture featuring intricate details (Cusack 
and Freer, 2008). This phenomenon of skeletal formation through mineral deposition is 
termed biomineralisation. 
The fossil record indicates that the process of biomineralisation has been occurring for 
more than 550 million years (Veis, 2010). The process of biomineralisation is often 
precisely controlled by a set of extracellular macromolecules including proteins, 
glycoproteins and polysaccharides, collectively called the shell matrix (Addadi and 
Weiner, 1992). Even though the shell matrix accounts for less than 5% of weight of the 
total shell weight, it controls several different aspects of shell formation including size, 
shape, the calcium carbonate polymorph (calcite vs aragonite), crystal organisation and 
crystal orientation (Marin et al., 2008, Arakaki et al., 2015).  
The extracellular matrix proteins in particular are responsible for crystal nucleation, 
encouraging crystal growth and stopping of crystal growth (Veis, 1990). Incorporation of 
macromolecules into the shell matrix protects the crystal lattice against fracture by 
creating defects, which will absorb stress and stop the progression of cracks (Aizenberg 
et al., 1995). These matrix proteins are highly acidic, phosphorylated, and have motifs 
such as Asp repeats and Ser-Ser repeats (Weiner and Hood, 1975). The highly acidic and 
negatively charged nature of these proteins may act as a template for mineralisation by 
providing calcium-binding sites (Alvares, 2014).  
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In vitro crystallisation experiments using shell matrix acidic proteins confirmed that they 
play a role in controlling crystal morphology and crystal polymorph (Feng, 2009). Many 
molluscan biomineralising proteins have been found so far and they can be grouped 
either based on pI values,  44 biomineralising protein are grouped according to pI values 
(Marin et al., 2008), or based on their osteogenic properties, 77 invertebrate skeletal 
nacre proteins are grouped together based on their osteogenic properties (Sarashina and 
Endo, 2006), or location (Kobayashi and Samata, 2006).  
4.1.2. Molluscan Shell Formation and Extrapallial Fluid 
Most mussel shells are made up of calcium carbonate. In contrast, the bivalves like the 
common blue mussel, Mytilus edulis, have shells of made up of outer prismatic calcite 
layer and inner nacreous aragonite layer (Figure 4-1) (Yin et al., 2005).  
 
  
Figure 4-1 The common blue mussel M. edulis. (A) An extrapallial space between mantle and shell of the 
M. edulis. (B) Schematic diagram of transverse section of the mantle edge of a bivalve (Behrens, 2007). 
In the common blue mussel, Mytilus edulis, the extrapallial (EP) fluid is secreted into the 
extrapallial space formed between the mantle and the shell (Figure 4-1 B). EP fluid has a 
higher concentration of Ca2+  ions compared to their  blood, suggesting that the 
extrapallial fluid has a role in shell formation (Crenshaw, 1972). Subsequent chemical 
analysis of EP fluid using SDS-PAGE showed that EP fluid contains five different 
proteins (Misogianes and Chasteen, 1979).  Hattan et al. identified the most abundant 
protein in extrapallial fluid, a 28 kDa protein, and named it extrapallial (EP) protein 
(Hattan et al., 2001a). Further work on the primary structure of this protein showed that 
the EP protein is made up of 213 amino acids in total, of which the first 23 amino acids 
constitute a secretion signal peptide (Yin et al., 2005). EP protein is highly glycosylated 
A B 
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and usually exists in disulphide linked dimeric form (Yin et al., 2005). The protein's 
secondary structure is stabilised by calcium binding (Hattan et al., 2001a).  
EP protein has many Glu and Asp acidic residues; which will further facilitate calcium 
binding; and make EP protein an ideal candidate for the development of synthetic 
biomineralising strategies to mimic nature.  
4.1.2 Rsn2 Protein 
Rsn2, a surfactant protein, is isolated from the foam nest of Túngara frog. The surfactant 
properties of this protein are described and proven, in section 2.5.  .  
4.2 Aims & Objectives 
Exploiting the role that EP protein plays in biomineral formation, combined with the 
surfactant properties of Rsn2, the strategy of stabilising droplets with Rsn2 and 
mineralising the droplets using EP protein aimed to direct mineral formation on surfaces 
that would otherwise not support mineral formation. 
Work describe by Ji.B et al  (Ji et al., 2010) was the precedent for this work about 
exploring the possibility of use of EP biomineralising protein with the aim of generating 
hybrid mineralised capsules as shown by Schulz.A et al (Schulz et al., 2011). 
The rationale was that Rsn2 being a surfactant protein will act on air-water interface and 
will stabilise the droplets, while the EP protein being a biomineralising protein will 
mineralise the droplets when subjected to calcium containing solution. Idea was to 
develop Ep-Rsn2 fusion protein, which would have the ability to stabilise and mineralise 
oil droplets. To ensure control of all parameters, a microfluidic on-chip approach was 
used to generate uniform bubbles. The mineralised droplets could be used for drug 
delivery, cosmetics, fabricating microcapsules, and other applications. 
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4.3 Method and Materials 
4.3.1 Rsn2 stabilised bubbles and droplets  
A microfluidics system was used to make bubbles and droplets of uniform size. The 
microfluidic chip used was designed and fabricated by Dr Jonathan McKendry. 
4.3.1.1 Fabrication of microfluidic chip 
The microfluidic chip was generated by casting polydimethylsiloxane (PDMS) elastomer 
on a Pyrex glass substrate (Li et al., 2014). The PDMS oligomer and curing agent 
(Sylgard 184, Dow Corning) were mixed in a ratio of 10:1, poured into a silicon master 
mould, and cured at 70⁰C overnight (Yin et al., 2009). The silicon master was fabricated 
by optical lithography, while the electrodes were configured by depositing a thick 
platinum film on the silicon master. The photoresist was deposited onto the silicon 
master, which protected the substrate against irradiation, such that it then makes the 
features that will template the channels when the PDMS is cast onto it (Hua and Pennell, 
2009).  
 
 
Figure 4-2 Schematic diagram of the microfluidics chip design used to form bubbles and oil droplets. 
Where the dimensions mentioned are channels’ widths, while the circles represents the inlet and outlet 
channels. 
4.3.1.2 Making droplets and bubbles 
The microfluidic chip (Figure 4-2) consists of parallel inlet flow channels separated by a 
distance of 1 mm. Each channel has uniform cross section dimensions of 100 µm width x 
50 µm height. The single outlet channel is wider with a cross section of 300µm wide x 50 
µm height. Polytetrafluoroethylene (PTFE) tubing (Cole Palmer, Hanwell, UK) of 100 
µm internal diameter and 300 µm outer diameter was inserted carefully into the outlet 
Rsn2 or 
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Pressure cone 
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reservoir to extend the reaction channel and allow collection of the product (Yashina et 
al., 2012). Optimisations of flow rate were carried out to reduce the size of bubbles to 
below 100 µm by changing flow rate from 1 µl/minutes to 10 µl/minutes in the flow 
cells.  For further experiments a flow rate of 5µl/minutes was used. Reagents (Rsn2, 
Nitrogen gas or per-fluorinated oil) were delivered through the inlets at flow rates of 5 
µl/minutes using precision syringe pumps (KD Scientific). The supply pressures (250 
mbar for Rsn2 and 212 mbar for nitrogen gas) were kept constant and bubbles of 
nitrogen gas or droplets of per-fluorinated oil were made at room temperature (22⁰C). A 
high-speed camera was used to capture images of the droplets/bubbles formed. The 
bubbles or droplets were transferred to a microscope slide for analysis by a Zeiss 
Axiovert light inverted microscope or Zeiss Axiophot fluorescence microscope. The 
images from microscopy were processed using ImageJ to facilitate measurement of the 
dimensions of the droplets/bubbles. 
4.3.2 EP-Rsn2 – cloning and protein production 
Unless otherwise stated, the method of protein production for developing EP-Rsn2 
recombinant protein was as described for IBS-Rsn2 in section 3.3. 
4.3.3 Inclusion body preparation 
Inclusion bodies containing insoluble protein are part of the pellet along with cell debris 
after centrifugation of the cell lysate. The cell pellet was resuspended in wash solution (5 
g l-1 methionine and 1 mM EDTA) and pelleted by spinning at 11,000 rpm for 20 
minutes. The wash step was performed three times. The pellet was resuspended and 
incubated on a magnetic stirrer at 4⁰C overnight in acetonitrile-water (1:1) solution with 
0.1% TFA. 
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4.4 Results 
4.4.1 EP-Rsn2 cloning 
4.4.1.1 Primer design 
An EP cDNA codon optimised for high level expression in E. coli and carried in a pET 
15 based expression vector was obtained from Prof Maggie Cusack. The EP gene was 
flanked by NdeI and XhoI restriction sites. Primers were designed to amplify the whole 
EP gene and fragments flanked with NdeI and AseI restriction sites that could be cloned 
into the NdeI site of existing pET28-Rsn2 vector to generate EP-Rsn2 fusion proteins. 
XhoI had to be replaced by AseI because XhoI has stop codon in its sequence and there 
were no directly available XhoI sites in pET28 to be used (the XhoI site is at the 3’ end 
of the EP coding sequence). AseI was selected because it has compatible cohesive ends 
with NdeI. Thus the AseI digested sticky end can be ligated to the NdeI half site, the 5’ 
end of the pET28-Rsn2 expression cassette, to generate EP-Rsn2 construct. The EP-Rsn2 
construct were flanked by NdeI on 5’ end and BamHI on the 3’ end.  
Full length EP protein was also expressed from the pET15 construct, but most of it was 
not folded and was found in inclusion bodies (Figure 4-3). Thus three sets of primers 
were designed to amplify different EP fragments to incorporate into Rsn2 fusions, all 
containing the N-terminal calcium binding domain (Figure 4-3). Shorter fragment lengths 
were made so that if full length (FL) FL EP-Rsn2 does not fold then a shorter fragment 
such as 76E EP-Rsn2 and 82S EP-Rsn2 might work. The first 76 (as in 76E) and 82 (as 
in 82S) amino acids were selected as they are followed by C1q sequence. This C1q 
sequence also plays an important role in biomineralisation of bones, but it is the highly 
charged and has glycosylation sites, and therefore might be difficult to fold (Kishore and 
Reid, 2000). Thus primers were designed to amplify the first 76 and 82 amino acid long 
fragment, which has better prospects of being folded when expressed as an Rsn2 fusion 
construct. Table 4-1 below shows the primer sequences. 
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Figure 4-3 The binding sites of the three sets of primers design for pET15 EP, which each result in 
amplification of a different size EP fragment.  
 Sequence Fwd (5’ -3’) Rev Primer Sequence For N-
terminal EP (5’- 3’) 
Ann 
Tem 
FL 
(218 AAs) 
AGCCATATGAACCCGGTG ATTAATGTGCAGCATAAAGCCGGT 53.7 
76E 
(76 AAs) 
AGCCATATGAACCCGGTG ATTAATTTCTTCGTGCAGATGTTT 48.1 
82S 
(82 AAs) 
AGCCATATGAACCCGGTG ATTAATGCTTTTGAAATATTCAAC 41.9 
 
Table 4-1 The EP fusion protein primer sequences, where ATTAAT is the restriction site for AseI, which 
has compatible ends with NdeI. Here AAs stand for amino acids.  
4.4.1.2 PCR 
PCR amplification was carried out at the annealing temperature specific to each primer 
pair, many times dictated by 3' primer annealing temperature is shown in Table 4-1. 
pET15-EP was used as a template to produce three different fragments of the EP coding 
sequence as PCR products. The first primer pair was used to amplify 654 bp coding for 
the full length EP gene, second primer pair was to amplify 228 bp coding for the N 
terminal 76 amino acids and third primer pair was for 246bp coding for the N terminal 82 
amino acids. The PCR products were purifies by agarose gel electrophoresis and each 
excised fragment was then purified using gel purification (Wizard® SV Gel and PCR 
Clean-Up System) to remove any contaminating product.  
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Figure 4-4 PCR amplification from EP pET15 using primers incorporating AseI restriction site to 
generate a fragment flanked with AseI and NdeI, (1) no plasmid as a negative control; (2) EP-FL; (3) EP-
82S; (4) EP-76E; (M) 1kb ladder promega and (M’) is 100bp Promega marker. 
4.4.1.3 Topo TA cloning and transformation 
3’ adenosine overhangs were added to each insert using Taq polymerase (GoTaq® Flexi 
DNA Polymerase # M8301). The gene was then recombined into pCR4.0-TOPO vector 
with complementary 3’ thymine overhangs which contains immobilised topoisomerase 
enzyme (Invitrogen). The Topo-TA cloned mixture was then transformed into One shot 
TOPO cells (using the manufacturer’s protocol), minipreped and DNA sequencing 
carried out to check that the TA-cloned fragments had the correct sequence. 
4.4.1.4 Subcloning 
Each EP coding sequence was then subcloned into the Rsn2 containing pET28 vector. 
The restriction enzymes NdeI (NEB) and AseI (NEB) were used to cut the insert out of 
the pCR4 vector producing sticky overhangs. In parallel, Rsn2 containing pET28 
expression plasmid was linearized with NdeI restriction enzyme (NEB) and 
dephosphorylated using alkaline phosphatase (NEB) to generate sticky overhangs 
compatible with the EP fragments. 
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Figure 4-5 Agarose gel electrophoresis of restriction digests of all three EP fragments in pCR4.0 TOPO 
generated using primers incorporating NdeI and AseI sites. (1) plasmid alone; (2) NdeI single digest; (3) 
AseI single digest; (4) EP-FL double digest; (5) EP-82S double digest; (6) EP-76E double digest; (M) 1kb 
ladder promega. Red arrows shows the linearised inserts of the correct size. 
The gel-purified EP fragments were ligated into Rsn2 containing pET-28 expression 
plasmid using T4 DNA ligase enzyme (NEB). Ligation reactions were incubated at 16⁰C 
overnight and were then transformed into chemically competent DH5 alpha (Subcloning 
Efficiency™ DH5α™ Competent Cells # 18265-017) using the manufacturer’s protocol.  
4.4.1.5 Orientation Screening  
Plasmid DNA was purified from transformed colonies and screened for the presence of 
the correct insert by subjecting it to NdeI and BamHI restriction digest. For this, several 
colonies were grown, minipreped, and the plasmids were used for restriction double 
digest. If the insert is in the correct orientation, carrying 5’NdeI and 3’AseI, then a band 
of the correct size will appear. If the insert is in the wrong orientation, a band 
corresponding to the Rsn2 cDNA alone will be visible. Thus double digest with NdeI and 
BamHI is an effective way of screening colonies. 
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Figure 4-6 Agarose gel electrophoresis results showing screening of plasmid from six EP82S-Rsn2 
colonies by restriction double digest. (1 to 6)  plasmid double digest using NdeI and BamHI; (7) Uncut 
plasmid; (M) 1kb ladder Promega. Red arrows indicate the excised bands of the correct size, suggesting 
that the colony has the correct orientation of the insert.  
Colonies were screened and those which contained inserts of the correct size e.g. colony 
6 in Figure 4-6 were sequenced.  The verified plasmids were then transformed into the 
Tuner (DE3) pLysS expression cells. 
4.4.2 Test expression 
Test expression was carried out to check for expression and solubility of the EP82S-Rsn2 
fusion protein, using a representative for all three EP-Rsn2 proteins. SDS-PAGE analysis 
suggested that the soluble protein expression is low for all EP-Rsn2 constructs at all 
IPTG concentrations (0.1mM, 0.4mM or 1 mM) tested. Further optimisations were 
carried out in an attempt to improve the yield of protein by decreasing the incubation 
temperature to 4⁰C post induction, and increasing incubation from 3 hours to overnight, 
but this did not result in any improvement in protein yield. 
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Figure 4-7 SDS-PAGE of EP82S-Rsn2 test expressions induced at different IPTG concentrations, (A) 
0.1mM; (B)0.4mM and (C) 1 mM IPTG ; (P) Pre-induced fraction; (T) Total post-induced fraction; (S) 
Soluble fraction; (I) Insoluble fraction and (M) Marker (7-175kD, NEB). 
4.4.3 EP pET15 protein expression and purification 
Upon successful transformation, test expression was carried out for all three EP-Rsn2 
fusion constructs. For all the three test expression, samples were incubated at 37⁰C after 
inducing with 1 mM IPTG. Post induced samples were then subjected to SDS-PAGE. 
SDS-PAGE analysis suggests that the soluble protein expression was low for all the three 
EP-Rsn2 constructs. Thus optimisations were made in order to get the protein insoluble 
fraction. For this, IPTG concentration was decreased to 0.4 mM from 1mM and the rest 
of the parameters constant. Post-induced samples were obtained at the end of 3 hours 
incubation at 37⁰C and were subjected to SDS-PAGE, which showed that the expressed 
protein is going in the insoluble fraction. Further trials were made by further reducing the 
IPTG concentration to 0.1mM and conducting SDS-PAGE analysis of the post induced 
samples, which also showed presence of expressed protein in insoluble fraction. 
Further optimisations were carried out by increasing the time of incubation after inducing 
the samples with 1 mM IPTG. The post induced samples were harvested after incubating 
them overnight at 37⁰C and subjecting to SDS-PAGE analysis.  The obtained results 
showed that the proteins were still insoluble.  
In order to give chaperons enough time for folding the expressed EP-Rsn2 proteins, the 
post induced incubation time was increased and simultaneously the induction was 
decreased by lowering the concertation of IPTG, so that proteins gets enough time to be 
folded and thereby they remain in the desired soluble fraction.  With this logic, the IPTG 
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concentration was decreased to 0.4mM and increased the time of incubation 
simultaneously. The post induced samples were subjected to SDS-PAGE, which revealed 
that the expressed protein was going in the insoluble fraction. So the next step was to 
further decrease IPTG concentration to 0.1mM and post induced samples were incubated 
overnight. The SDS-PAGE gel showed that the expressed protein was still going in the 
insoluble fraction. 
After unsuccessful protein expression by reducing the IPTG concentration and increasing 
the time of incubation, the next step tried was to decrease the temperature of post 
induced incubation from 37⁰C to 4⁰C. The decrease in incubation temperature will result 
in lowering of basal metabolic rate and thereby reducing the kinetics of protein 
expression. Thus the chance of protein being folded and in the soluble fraction increases. 
To achieve this, samples were induced with IPTG (0.1mM, 0.4mM, 1mM) and incubated 
at 4⁰C overnight. The resultant samples were run on the SDS-PAGE for analysis, which 
showed that protein was still going in the insoluble fraction. 
Further optimisations were carried out in an attempt to improve the yield of protein by 
trying a different type of expression cells like BL21(DE3), and trying out all of the above 
mentioned combination of decreasing IPTG concentration along with the incubation 
temperature to 4⁰C and increasing the time of incubation from 3 hours to overnight, but 
this did not result in any improvement in protein yield. 
4.4.4 Inclusion body preparation 
Samples from all three wash steps and the acetonitrile-water sample were analysed by 
SDS-PAGE alongside the nickel affinity purification samples. The gel revealed that EP 
protein was well expressed (Figure 4-8), but mostly present in the insoluble fraction and 
was mostly solubilized by the acetonitrile-water extraction.  
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Figure 4-8 SDS-PAGE of large scale expression of EP from pET15 (1) Methionine wash 1 of the cell 
pellet; (2) Methionine wash 2 of the cell pellet; (3) Methionine wash 3 of the cell pellet; (4) After 
overnight extraction of protein from inclusion bodies using acetonitrile-water (50:50); (5) Elution fraction 
of the cell lysate supernatant subjected to Ni affinity chromatography and (M) Marker (7-175kD, NEB). 
Since the EP protein was already of reasonable purity, it was lyophilised without further 
purification. Attempts were then made to solubilise lyophilised EP into pure water or 
buffers. However, the EP lyophilizate was not soluble in water or buffers at a range of pH 
3-10. 
4.4.5 Formation of Rsn2 stabilised bubbles 
As a proof of principle that Rsn2 could stabilise the formation of micro-scale bubbles, 
nitrogen gas bubbles were made in an aqueous solution of Rsn2. Nitrogen gas and Rsn2 
solution were passed through inlet flow cells on a microfluidic chip (Figure 4-9A). At the 
pressure cone that is generated at the meeting point of aqueous phase and nitrogen gas, 
bubbles are formed. The bubbles then pass through the collection tube and can be 
collected in an eppendorf tube. Being less dense than the aqueous phase, the bubbles tend 
to float on the liquid in the eppendorf.  
At a flow rate of 5 µl/minutes bubbles of 118.5 ± 7.8 µm diameter were generated. 
Figure 4-9 shows bubble formation, and a representative view of the bubbles formed. 
These bubbles were stable for more than 24 hours but upon incubation at 4⁰C for more 
than 48 hours they started to coalescence giving a population of heterogeneous sized 
bubbles. No bubbles were formed in control sample, where buffer was used in place of 
Rsn2. A range of concentrations from 0.1-1 mg/ml  Rsn2 were used to make bubbles, but 
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no bubbles were formed at a lower concentrations showing that at least 1 mg/ml Rsn2 
was required for bubble formation. 
A 
 
B 
 
C 
 
D 
 
 
Figure 4-9 illustrates the process of Rsn2-stabilized N2 bubble formation. Where (A) is the image of the 
pressure cone formed at the microfluidic junction where Rsn2 solution and nitrogen gas meet, resulting in 
formation of bubbles, (B) shows bubbles passing through the collection tube, (C) shows a mass of bubbles 
floating in an eppendorf tube, and (D) shows the bubbles viewed by light microscopy. 
4.4.6 Formation of Rsn2 stabilised droplets  
Rsn2-stabilised bubbles of nitrogen gas were made in a microfluidic device as a prelude 
to using Rsn2 in the device to form stable droplets of immiscible liquids that can be 
mineralised to generate nanoparticles. Perfluorinated oil was passed through one 
microfluidic inlet channel instead of nitrogen gas to generated Rsn2 stabilised oil 
droplets. The Rsn2 stabilised droplets were examined using light microscopy (Figure 
4-10A). In subsequent experiments Rsn2 was replaced with iLOVRsn2, a fluorescent 
tagged Rsn2 protein (section-2.4.1), to produce iLOVRsn2 stabilised fluorescent oil 
droplets. Perfluorinated oil was selected as it is neutral in buoyancy which will allow 
droplet emulsion to remain suspended in solution. If the droplets are neutral in buoyancy, 
there will be less tendency for them to phase separate, which will also be important for 
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mineralisation. While, iLOVRsn2 facilitates monitoring of the localisation of partition 
between droplet (surface) and bulk aqueous phase formed. Droplets of 49.48 ± 0.96 µm 
diameter were formed at a constant flow rate of 5 µl/minutes for both solutions. The 
droplets were examined by fluorescence microscopy, where the intrinsic fluorescence of 
the iLOV fusion partner was used for tracing Rsn2. Figure 4-10 shows a representative 
view of the droplets formed. Fluorescence was only found outside of the droplets, 
confirming that Rsn2 is working at the oil buffer interface to stabilise the oil droplets 
formed. These droplets were stable for more than 6 months upon subsequent incubation 
at 4⁰C. In contrast, the control sample, where only buffer was used in place of Rsn2 
solution, immiscible layers of oil and buffer were found. The obtained droplets were 
washed to confirm that Rsn2 was at the surface, but upon washing the droplets 
disintegrated suggesting Rsn2 is required in solution for droplet stabilisation. 
 
  
Figure 4-10 Representative image of (A) Rsn2 stabilised oil droplets captured using light microscope and 
(B) iLOVRsn2 stabilised oil droplets captured using fluorescence microscope. Scale bar = 50 µm 
After producing droplets with iLOVRsn2 on the surface, the aim was to biomineralise the 
droplets using EP-Rsn2 fusion construct by incubating them with the mineralising 
solution. EP protein being a biomineralising protein would bind to calcium and would 
biomineralise the droplets to generate hybrid biomineralised capsules.  
In order to achieve this, attempts were made for generating Ep-Rsn2 fusion constructs, 
which were then used for protein production. 
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4.5 Discussion and future work 
This chapter describes work undertaken in an effort to demonstrate the use of EP protein 
to direct biomineralisation onto surfaces that do not naturally support this process. 
Specifically, the aim was to make mineralised droplets stabilised by surfactant Rsn2 
protein and mineralising them with biomineralising EP protein functionality.  
Further, the aim was to develop a mineralised material mimicking nacre or bone-like 
tissue. To achieve this, the material surface would be coated with EP-Rsn2 and then it 
would be allowed to mineralise by dipping in calcium carbonate solution. This coating 
and mineralising steps might results in a layer of mineral crystal, which would resemble 
a nacre or a de-cellularised bone. A de-cellularised bone is made up of mineralised 
calcium and protein; the only difference will be in the type of protein and mineral formed 
(Hydroxylapatite in bone vs calcite if EP is used). 
For this, EP protein was recombinantly over-expressed in E. coli as a His-tagged fusion 
protein, or as a tagged fusion with Rsn2 proved to be largely insoluble, most likely 
forming inclusion bodies. Native EP protein is secreted into the extra pallial space by the 
epithelial cells of the mollusc's mantle. This might have an impact on the folding and 
solubility of the EP protein in vivo. To address this challenge, it might be advantageous to 
produce EP containing proteins using prokaryotic secreting, or eukaryotic systems, like 
Pichia pastoris, for protein expression (Rosano and Ceccarelli, 2014).  
Bacterial protein expression systems are commonly used as the cells are easy to culture, 
grow fast and generate good yields of recombinant protein (Khow and Suntrarachun, 
2012). However, eukaryotic protein expression systems offer advantages including more 
native-like post translational modification. This may be important for EP which is 
normally glycosylated (Yin et al., 2005). If a secreting expression system were used for 
recombinant EP-Rsn2 expression, there is a high chance of excessive foaming of the 
culture medium due to the surfactant nature of Rsn2 component in the recombinant 
fusion protein and this may complicate cell culture. Other possibilities include exploring 
the use of insect cell or Pichia pastoris expression systems for the EP-Rsn2 protein 
expression, but these also typically require some aeration or aggitation.  
Native EP protein has a low pI and calcium ions are needed for its stabilisation in its 
native form (Feng, 2009). Thus addition of calcium ions in the buffer used for re-
suspending the powdered lyophilised EP might prove to be beneficial. The other 
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possibility is that the protein needs to be purified better first, e.g. by RP-HPLC or 
denatured with a chaotrope and refolded from that denatured state. 
The N-terminus of EP protein has a short calcium-binding peptide with repeat sequence 
of histidine and aspartate residues  ‘DDHHDDHHD’ (Hattan et al., 2001b), one can use 
this short calcium-binding peptide to make EP-Rsn2 recombinant fusion construct. This 
shorter recombinant protein might help in protein folding and result in protein 
solubilisation. Another possibility is to try different biomineralising proteins as fusion 
partners with Rsn2. For example a 23-kD silicatein-α protein, this protein has been used 
for the formation of synthetic siliceous spicules (Morse, 2005). Osteopontin derived short 
peptides like FHRRIKA (Table 3-2) found in extracellular matrix of human bone could 
be used for biomineralisation.  
In summary, attempts were made to obtain soluble recombinant EP-Rsn2 protein but 
were unsuccessful. The low solubility could perhaps be attributed to native EP protein 
having glycosylation sites, and glycosylation may be needed for its solubility and 
function in its native form. More work is needed to explore the possible options for 
production of soluble EP-Rsn2 protein. Upon successful expression of EP-Rsn2 protein, 
production of mineralised droplet should be possible. 
In parallel, microfluidics was selected for making monodispersed droplets, as it gives a 
precise control over the production conditions, including the volume of droplet and 
mixing of their contents, along with the reproducibility and scalability (Ralf et al., 2012). 
Many have used microfluidics to make droplet emulsions and have managed to get them 
of varying sizes (1 µm to 100’s of µm) (Ralf et al., 2012, Baret, 2012). Although the use 
of surfactant in emulsion formation is inevitable, none have used natural protein 
surfactants for droplet emulsion stabilisation. Saito et al. and Van Dijke et al. reported 
successful preparation of emulsions using protein from milk, egg white or soya bean 
flour in combination with various oils, but none of these proteins are classed as 
biosurfactants (Sahin et al., 2016, van Dijke et al., 2010, Saito et al., 2005). Schulz et al. 
have used hydrophobins for stabilising oil droplet, which were then used to mineralise 
but did not use microfluidics for making the emulsions (Schulz et al., 2011).  
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5 General discussion 
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General discussion 
The work described in this thesis is about using the biophysical properties of Rsn2 for 
applications in cell patterning, functionalising scaffolds and stabilising oil droplets 
emulsion. 
Rsn2, a protein with intrinsic surfactant activity, adsorbs to hydrophobic surfaces using 
non-covalent interactions, and makes the material surface hydrophilic. The Rsn2 surface 
coat forms rapidly and can be applied by simply dip coating with the Rsn2 solution. The 
Rsn2 surface coating method developed is reproducible and does not require any 
chemical or physical pre-treatment. Moreover, Rsn2 has demonstrated its ability to coat a 
range of hydrophobic polymeric surfaces, as shown by water contact angle and 
persistence experiments (section- 2.4). The resulting Rsn2 coating proved to be stable 
and persistent, and Rsn2 coated surfaces were then able to be used to promote cell 
adhesion, develop functionalised polymeric scaffolds and stabilise oil droplet emulsions. 
The ability to produce recombinant Rsn2 fusion proteins without interfering with the 
proteins’ surface activity was exploited. The results from section 3.4.1 showed that Rsn2 
can successfully act as a fusion partner for several integrin binding sequence (IBS) 
peptides, and are relatively easy to express and purify. Given the experience with IBS 
peptide and iLOV domain fusions, it is highly likely that Rsn2 can be used to produce 
surface active fusions for other peptides or proteins of interest. In the recombinant Rsn2 
fusion proteins developed, the Rsn2 acts as the anchor to the surface leaving the fusion 
partner accessible, active and solvent exposed. 
Rsn2 also provides a distinct advantage for creating mixed protein surfaces, which can be 
applied for mimicking extracellular matrix (ECM) or by presenting growth factors, with 
application in tissue engineering. Rsn2 coatings could find their applications in number 
of places, such as coating cell culture surfaces; for immobilising enzymes; for 
diagnostics biosensor application; or for studying protein-protein interactions. 
Although hydrophobin reduces interfacial surface tension to a greater extent, as 
discussed in section 1.4, and has demonstrated equally good application possibilities 
when compared to Rsn2 (Wösten and Scholtmeijer, 2015, Hou et al., 2009, Linder et al., 
2002).  For hydrophobin, in order to form assembly on solid materials, aqueous solution 
of protein is added onto the cleaned material surface and incubated overnight at 25°C in 
the presence of 0.02% NaN3.  This is followed by harsh extraction steps, which needs to 
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be carried out using 2% SDS at 100°C, in order to form sheets of hydrophobins (Wösten 
et al., 1995, Wösten et al., 1994). Thus Rsn2 was selected as it provides an easy method 
to develop a coating technique as compared to hydrophobin, which requires 
comparatively harsh and prolonged treatment to form a coat. 
Moreover, fungal spores are well-known to cause respiratory allergies. A study conducted 
by Weichel M et al showed that hydrophobins, which coats the fungal spores, can also 
trigger allergic response (Weichel et al., 2003). In addition, hydrophobins aggregates at 
the interface to make amyloid like film, which can uptake the congo-red staining (Kwan 
et al., 2006). However, in the histology world congo-red is used to stain amyloid plaques 
of patients with Alzheimer's disease (Wu et al., 2012). Thus the ability of hydrophobin to 
trigger allergenic response and uptake the congo-red stain, will limit its applicability in 
cell based therapy. 
A potentially productive avenue is to explore the idea of using SPLUNC1 for 
applications in humans. SPLUNC1 is a surfactant protein isolated from the upper 
respiratory tract of humans, more information in section-1.6. In comparison with Rsn2, 
SPLUNC1 is difficult to express and purify from the constructs so far tested, requiring 
carefully optimised culture temperature, IPTG levels and specialized E. coli strains. If 
allergenicity did not prove to be a problem, Rsn2 production could be more easily scaled 
up and economic in production.  The insight of the mechanisms of Rsn2 and SPLUNC1 
could be perhaps used to produce humanised Rsn2 sequences. Moreover, Rsn2 was 
selected as a candidate to develop a model system for future replication with SPLUNC1. 
To conclude, the surfactant properties of Rsn2 can be used for many potential biomedical 
applications and can act as a model system for developing SPLUNC1 application 
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